KEWAUNEE SCIENTIFIC CORP /DE/
10-Q, 2000-03-14
LABORATORY APPARATUS & FURNITURE
Previous: FORT JAMES CORP, SC 13G/A, 2000-03-14
Next: KIT MANUFACTURING CO, 10-Q, 2000-03-14



<PAGE>


                UNITED STATES SECURITIES AND EXCHANGE COMMISSION

                              Washington, DC 20549

                                    FORM 10-Q

 -----
|  X  |     Quarterly Report Pursuant to Section 13 or 15(d) of the Securities
 -----      Exchange Act of 1934

                           For the quarterly period ended January 31, 2000

 -----
|_____|     Transition Report Pursuant to Section 13 or 15(d) of the Securities
            Exchange Act of 1934

For the transition period from ____________ to _____________

Commission file number 0-5286

                         KEWAUNEE SCIENTIFIC CORPORATION

             (Exact name of registrant as specified in its charter)

          Delaware                                      38-0715562
- --------------------------------------------------------------------------
(State or other jurisdiction of                      (I.R.S.Employer
 incorporation or organization)                     Identification No.)

2700 West Front Street
Statesville, North Carolina                                28677
- --------------------------------------------------------------------------
(Address of principal executive offices)                 (Zip Code)

                                (704) 873-7202
              ----------------------------------------------------
              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes X No
                                      ---  ---
As of March 10, 2000, the Registrant had outstanding 2,465,871 shares of Common
Stock.

Pages:  This report, excluding exhibits, contains 15 pages numbered
sequentially from this cover page.

<PAGE>

                         KEWAUNEE SCIENTIFIC CORPORATION

                               INDEX TO FORM 10-Q

                 FOR THE QUARTERLY PERIOD ENDED JANUARY 31, 2000
<TABLE>
<CAPTION>
                                                                                         Page
                                                                                        Number
                                                                                        ------
<S>                                                                                       <C>
PART I.  FINANCIAL INFORMATION
- ------------------------------

Item 1.        Financial Statements

               Condensed Statements of Operations -
                Three months and nine months
                ended January 31, 2000 and 1999                                            3

               Condensed Balance Sheets - January 31, 2000
                and April 30, 1999                                                         4

               Condensed Statements of Cash Flows -
                Nine months ended January 31, 2000 and 1999                                5

               Notes to Condensed Financial Statements                                     6

Item 2.        Management's Discussion and Analysis of Financial
                Condition and Results of Operations                                        8

Review by Independent Accountants                                                         12

Report by Independent Accountants                                                         13

PART II.  OTHER INFORMATION
- ---------------------------

Item 6.        Exhibits and Reports on Form 8-K                                           14


SIGNATURE                                                                                 15
</TABLE>

<PAGE>

                          Part 1. Financial Information

         Item 1.  Financial Statements

                         Kewaunee Scientific Corporation
                       Condensed Statements of Operations
                                   (UNAUDITED)
<TABLE>
<CAPTION>

                                                         Three months ended                  Nine Months ended
                                                             January 31                         January 31
                                                             ----------                         ----------
                                                        2000              1999             2000            1999
                                                        ----              ----             ----            ----
                                                               ($ IN THOUSANDS, EXCEPT PER SHARE DATA)
<S>                                                   <C>              <C>              <C>              <C>
Net sales                                             $ 16,945         $ 18,404         $ 56,561         $ 57,281
Cost of products sold                                   12,768           14,302           43,408           44,733
                                                      --------         --------         --------         --------

Gross profit                                             4,177            4,102           13,153           12,548
Operating expenses                                       3,070            3,000            9,522            9,108
                                                      --------         --------         --------         --------

Operating earnings                                      1,107            1,102            3,631            3,440
Interest expense                                          (32)             (37)            (123)             (63)
Other income (expense), net                                24               (5)             266              (33)
                                                     --------         --------         --------         --------

Earnings before income taxes                            1,099            1,060            3,774            3,344
Income tax expense                                        220              425            1,250            1,338
                                                     --------         --------         --------         --------

Net earnings                                        $    879         $    635         $  2,524         $  2,006
                                                    ========         ========         ========         ========

Net earnings per share-
   Basic                                            $   0.36         $   0.26         $   1.03         $   0.83
   Diluted                                              0.35             0.26             1.02             0.81

  Average number of common shares
   outstanding (in thousands)-
   Basic                                               2,464            2,436            2,453            2,431
   Diluted                                             2,482            2,467            2,475            2,464
</TABLE>

          SEE ACCOMPANYING NOTES TO CONDENSED FINANCIAL STATEMENTS.

                                       3
<PAGE>


                         Kewaunee Scientific Corporation
                            Condensed Balance Sheets
                                ($ IN THOUSANDS)
<TABLE>
<CAPTION>
                                                                          January 31                April 30
                                                                             2000                     1999
                                                                         -----------                --------
                                                                         (Unaudited)
<S>                                                                        <C>             <C>
ASSETS
- ------
Current assets:
  Cash and cash equivalents                                                $      8         $      8
  Receivables                                                                14,731           17,231
  Inventories                                                                 3,498            2,940
  Deferred income taxes                                                       1,026            1,026
  Prepaid expenses and other current assets                                     518              626
                                                                           --------         --------
Total current assets                                                         19,781           21,831
                                                                           --------         --------

Property, plant and equipment, at cost                                       32,931           30,302
Accumulated depreciation                                                    (19,632)         (18,177)
                                                                           --------         --------
Net property, plant and equipment                                            13,299           12,125
                                                                           --------         --------
Other assets                                                                  2,329            2,079
                                                                           --------         --------

Total Assets                                                               $ 35,409         $ 36,035
                                                                           ========         ========

LIABILITIES AND STOCKHOLDERS' EQUITY
- ------------------------------------
Current liabilities:
  Short-term borrowings                                                   $    458         $    939
  Accounts payable                                                           4,776            6,566
  Employee compensation and amounts                                          1,643            1,973
         withheld

  Other current liabilities                                                  1,998            2,194
                                                                          --------         --------
Total current liabilities                                                    8,875           11,672
                                                                          --------         --------

Deferred income taxes                                                        1,074            1,074
Accrued employee benefit plan costs                                          1,257            1,257
Total Liabilities                                                           11,206           14,003
                                                                          --------         --------

Stockholders' equity:
  Common stock                                                              6,550            6,550
  Additional paid-in-capital                                                   83              148
  Retained earnings                                                        18,487           16,429
  Common stock in treasury, at cost                                          (917)          (1,095)
                                                                         --------         --------
Total stockholders' equity                                                 24,203           22,032
                                                                         --------         --------

Total Liabilities and Stockholders' Equity                                 35,409           36,035
                                                                         ========         ========
</TABLE>



            SEE ACCOMPANYING NOTES TO CONDENSED FINANCIAL STATEMENTS.

                                       4
<PAGE>


                         Kewaunee Scientific Corporation
                       Condensed Statements of Cash Flows
                                   (Unaudited)
                                ($ IN THOUSANDS)
<TABLE>
<CAPTION>
                                                                                       Nine months ended
                                                                                          January 31
                                                                                          ----------
                                                                                   2000                 1999
                                                                                   ----                 ----
<S>                                                                             <C>                  <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings                                                                    $ 2,524         $ 2,006
Adjustments to reconcile net earnings to net cash
provided by (used in) operating activities:
  Depreciation and amortization                                                   1,496           1,262
  Provision for bad debts                                                            72             107
  (Increase) decrease in receivables                                              2,428          (2,744)
  (Increase) decrease in inventories                                               (558)            130
  Decrease in accounts payable and
    other current liabilities                                                    (2,316)           (959)
  Other, net                                                                       (143)           (245)
                                                                                -------         -------

Net cash provided by (used in) operating activities                               3,503            (443)
                                                                                -------         -------

CASH FLOWS FROM INVESTING ACTIVITIES:
  Capital expenditures                                                           (2,670)         (2,969)
                                                                                -------         -------

Net cash used in investing activities                                            (2,670)         (2,969)
                                                                                -------         -------

CASH FLOWS FROM FINANCING ACTIVITIES:
  Net increase (decrease) in short-term                                           (481)          2,422
         borrowings
  Dividends paid                                                                  (466)           (389)
  Proceeds from exercise of stock options                                          114              70
                                                                               -------         -------

Net cash provided by (used in) financing activities                               (833)          2,103
                                                                               -------         -------

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS                                     0          (1,309)

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD                                       8           1,809
                                                                               -------         -------

CASH AND CASH EQUIVALENTS, END OF PERIOD                                       $     8         $   500
                                                                               =======         =======

SUPPLEMENTAL DISCLOSURE:
  Interest paid                                                                $   134         $    49
  Income taxes paid                                                            $   739         $ 1,732
</TABLE>

            SEE ACCOMPANYING NOTES TO CONDENSED FINANCIAL STATEMENTS.

                                       5
<PAGE>


                         Kewaunee Scientific Corporation
                     Notes to Condensed Financial Statements
                                   (unaudited)

A.  Financial Information
- -------------------------

The unaudited interim condensed financial statements of Kewaunee Scientific
Corporation (the "Company" or "Kewaunee") have been prepared pursuant to the
rules and regulations of the Securities and Exchange Commission (the
"Commission"). Accordingly, certain information and footnote disclosures
normally included in financial statements prepared in accordance with generally
accepted accounting principles have been condensed or omitted. These interim
condensed financial statements should be read in conjunction with the financial
statements and notes included in the Company's 1999 Annual Report to
Stockholders.

The preparation of the financial statements in conformity with generally
accepted accounting principles requires management to make certain estimates
and assumptions that affect reported amounts and disclosures.  Actual results
could differ from those estimates.

In the opinion of management, the interim condensed financial statements reflect
all adjustments (consisting only of normal recurring adjustments) necessary for
a fair presentation of the interim periods. The results of operations for the
interim periods are not necessarily indicative of the results of operations to
be expected for the full year.

B.  Inventories
- ---------------

Inventories consisted of the following (in thousands):
<TABLE>
<CAPTION>
                                               Jan. 31, 2000           April 30,1999
                                               -------------           -------------
<S>                                             <C>                     <C>
Finished products                                    $  575               $  594

Work in process                                         968                  911
Raw materials                                         1,955                1,435
                                                     ------               ------
                                                     $3,498               $2,940
                                                     ======               ======
</TABLE>

C.  Balance Sheet
- -----------------

The Company's April 30, 1999 condensed balance sheet as presented herein is
derived from audited financial statements, but does not include all disclosures
required by generally accepted accounting principles.

                                       6
<PAGE>

D.       Segment Information
- ----------------------------

The following table shows net sales and profits by business segment for three
months and nine months ended January 31, 2000 and 1999.
<TABLE>
<CAPTION>
                           Laboratory     Technical
                            Products      Products         Corporate       Total
                           ----------     ---------        ---------       -----
<S>                         <C>           <C>               <C>            <C>
Three months ended
January 31, 2000
- ------------------

Revenues from
 external customers          $14,926        $ 2,019            $--         $16,945
Intersegment revenues             --             85            (85)             --
Segment profit                 1,204            194           (299)          1,099


Three months ended
January 31, 1999
- ------------------

Revenues from
 external customers          $15,826        $ 2,578            $--         $18,404
Intersegment revenues             --             90            (90)             --
Segment profit                 1,142            111           (193)          1,060


Nine months ended
January 31, 2000
- -----------------

Revenues from
 external customers          $47,349        $ 9,212            $--         $56,561
Intersegment revenues             --            262           (262)             --
Segment profit                 3,286            810           (322)          3,774


Nine months ended
January 31, 1999
- -----------------

Revenues from
 external customers          $50,168        $ 7,113            $--         $57,281
Intersegment revenues             --            366           (366)             --
Segment profit                 3,224            421           (301)          3,344
</TABLE>

                                       7
<PAGE>


                  Item 2.  Management's Discussion and Analysis

                of Financial Condition and Results of Operations

The Company's 1999 Annual Report to Stockholders contains management's
discussion and analysis of financial condition and results of operations at and
for the year ended April 30, 1999. The following discussion and analysis
describes material changes in the Company's financial condition since April 30,
1999. The analysis of results of operations compares the three months and nine
months ended January 31, 2000 with the comparable periods of the prior fiscal
year.

Results of Operations
- ---------------------

The Company recorded sales of $16.9 million for the three months ended January
31, 2000, down 7.9% from sales of $18.4 million for the comparable period of the
prior year. Sales for the nine months ended January 31, 2000 were $56.6 million,
down 1.3% from sales of $57.3 million in the comparable period of the prior
year.

The lower sales for the quarter reflect a softer industrial research market for
laboratory products, as well as the impact of customer delays in placing orders
for technical furniture products until after the beginning of the calendar year
due to Y2K concerns. The softer industrial research market was also the primary
factor in the lower sales for the nine months ended January 31, 2000.

The gross profit margin for the quarter ended January 31, 2000 was 24.7% of
sales, as compared to 22.3% of sales in the comparable quarter of the prior
year. The gross profit margin for the nine months ended January 31, 2000 was
23.3%, as compared to 21.9% in the comparable period of the prior year. The
increase in the gross profit margins for the quarter was a result of improved
manufacturing efficiencies and reduced manufacturing costs provided by the
Company's capital investments at its Statesville location.

Operating expenses for the quarter ended January 31, 2000 were $3.1 million, or
18.1% of sales, as compared to $3.0 million, or 16.3% of sales, in the
comparable quarter of the prior year. Operating expenses for the nine months
ended January 31, 2000 were $9.5 million, or 16.8% of sales, as compared to $9.1
million, or 15.9% of sales, in the comparable period of the prior year. The
increase in operating expenses for the quarter and nine months was primarily
attributable to increased compensation and other employee costs.

                                       8
<PAGE>

Operating earnings of $1.1 million and $3.6 million were recorded for the three
months and nine months ended January 31, 2000, respectively. This compares to
operating earnings of $1.1 million and $3.4 million for the comparable periods
of the prior year.

Interest expense was $32,000 and $123,000 for the three months and nine months
ended January 31, 2000, respectively, compared to $37,000 and $63,000 for the
comparable periods of the prior year. The increase in interest expense in the
current year resulted primarily from higher levels of debt under the Company's
revolving credit facility.

Other income was $24,000 and $266,000 for the three months and nine months ended
January 31, 2000, respectively, compared to other expenses of $5,000 and $33,000
for the comparable periods of the prior year. Other income of $19,000 and
$244,000 for the three months and nine months of the current year, respectively,
was recorded resulting from collections associated with litigation settlements
with certain suppliers for overcharges in earlier years. No significant
additional collections are expected in this matter.

Income tax expense of $220,000 and $1,250,000 was recorded for the three months
and nine months ended January 31, 2000, respectively, as compared to income tax
expense of $425,000 and $1,338,000 recorded for the comparable periods of the
prior year. The effective tax rate was approximately 20% for the three months
ended January 31, 2000 and 33.1% for the nine months ended January 31, 2000. The
effective tax rate was 40% for the three and nine months ended January 31, 1999.
The lower effective tax rate for the current quarter is a result of tax credits
available due to the Company's increased research and development expenditures
and increased purchases of new manufacturing machinery at the Statesville
location. The Company is continuing to quantify earned tax credits, and
anticipates that additional credits will favorably affect the Company's
effective tax rate for the fourth quarter of the current year, with a return to
a normal tax rate thereafter.

Net earnings of $879,000 and $2.5 million, or $.35 per diluted share and $1.02
per diluted share, were recorded for the three months and nine months ended
January 31, 2000, respectively. This compares to net earnings of $635,000 and
$2.0 million, or $.26 per diluted share and $.81 per diluted share,
respectively, for the comparable periods of the prior year.

                                       9
<PAGE>

Liquidity and Capital Resources
- -------------------------------

Historically, the Company's principal sources of liquidity have been funds
generated from operations, supplemented as needed by short-term borrowings. The
Company believes that these sources will be sufficient to support ongoing
business levels, including capital expenditures through the current fiscal year.

The Company had working capital of $10.9 million at January 31, 2000, as
compared to $10.2 million at April 30, 1999. The ratio of current assets to
current liabilities was 2.23-to-1 at January 31, 2000, as compared to 1.87-to-1
at April 30, 1999. At January 31, 2000, advances of $458,000 were outstanding
under the Company's revolving credit facility, as compared to advances of
$939,000 outstanding at April 30, 1999. No advances were outstanding under the
Company's equipment loan component of the credit facility at January 31, 2000 or
April 30, 1999.

The Company's operations provided cash of $3,503,000 during the nine months
ended January 31, 2000, primarily from operating earnings and a reduction in
accounts receivable, partially offset by a decrease in accounts payable. The
Company's operations used cash of $443,000 during the nine months ended January
31, 1999, primarily to support increases in customer receivables and reductions
in accounts payable and other current liabilities.

During the nine months ended January 31, 2000, the Company used cash of
$2,670,000 for capital expenditures, primarily production equipment, compared to
the use of $2,969,000 for capital expenditures in the comparable period of the
prior year.

Year 2000
- ---------

As of the date of this Form 10-Q, the Company believes it has resolved the
potential impact of the year 2000 issue on its processing of date-sensitive
information in its operation and control systems. The Company, to date, has not
experienced any negative effects due to Y2K problems, either internally or with
its customers or vendors. The Company's expenditures related to Y2K compliance
have been less than $100,000, and substantially all of these expenditures were
expensed in fiscal year 2000.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
- --------------------------------------------------------------------------------

Certain statements in this report constitute "forward-looking" statements within
the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform
Act"). Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that could significantly impact results or

                                       10
<PAGE>

achievements expressed or implied by such forward-looking statements. These
factors include, but are not limited to, economic, competitive, governmental,
and technological factors affecting the Company's operations, markets, products,
services, and prices. The cautionary statements made pursuant to the Reform Act
herein and elsewhere by the Company should not be construed as exhaustive or as
any admission regarding the adequacy of disclosures made by the Company prior to
the effective date of the Reform Act. The Company cannot always predict what
factors would cause actual results to differ materially from those indicated by
the forward-looking statements. In addition, readers are urged to consider
statements that include the terms "believes", "belief", "expects", "plans",
"objectives", "anticipates", "intends" or the like to be uncertain and
forward-looking.

                                       11
<PAGE>


                        REVIEW BY INDEPENDENT ACCOUNTANTS

A review of the interim financial information included in this Quarterly Report
on Form 10-Q for the three months and nine months ended January 31, 2000 has
been performed by PricewaterhouseCoopers LLP, the Company's independent
accountants. Their report on the interim financial information follows.

                                       12
<PAGE>

REPORT OF INDEPENDENT ACCOUNTANTS

To the Board of Directors and Stockholders of
Kewaunee Scientific Corporation
Statesville, North Carolina

We have reviewed the accompanying condensed balance sheet of Kewaunee Scientific
Corporation as of January 31, 2000, and the related statements of operations for
each of the three-month and nine-month periods ended January 31, 2000 and 1999
and the statements of cash flows for the nine-month periods ended January 31,
2000 and 1999. These financial statements are the responsibility of the
Company's management.

We conducted our review in accordance with standards established by the American
Institute of Certified Public Accountants. A review of interim financial
information consists principally of applying analytical procedures to financial
data and making inquiries of persons responsible for financial and accounting
matters. It is substantially less in scope than an audit conducted in accordance
with generally accepted auditing standards, the objective of which is the
expression of an opinion regarding the financial statements taken as a whole.
Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material modifications that should
be made to the accompanying interim financial information for it to be in
conformity with generally accepted accounting principles.

We previously audited in accordance with generally accepted auditing standards,
the balance sheet as of April 30, 1999 and the related statements of operations,
of stockholders' equity, and of cash flows for the year then ended (not
presented herein), and in our report dated June 3, 1999 we expressed an
unqualified opinion on those financial statements. In our opinion, the
information set forth in the accompanying condensed balance sheet as of April
30, 1999, is fairly stated in all material respects in relation to the balance
sheet from which it has been derived.

PricewaterhouseCoopers LLP
Charlotte, North Carolina

February 11, 2000

                                       13
<PAGE>

                           PART II. OTHER INFORMATION

Item 5.        Other Information

               William A. Shumaker, President and Chief Operating Officer of the
               Company, was elected a director of the Company on February 23,
               2000.

Item 6.        Exhibits and Reports on Form 8-K

               (a)    Exhibits

                      10.38      Agreement dated as of November 12, 1999
                                 between William A. Shumaker and the Registrant.
                      10.39      Agreement dated as of November 12, 1999
                                 between D. Michael Parker and the Registrant.
                      10.40      Agreement dated as of November 12, 1999 between
                                 James J. Rossi and the Registrant.
                      10.41      Agreement dated as of January 20, 2000 between
                                 Kurt P. Rindoks and the Registrant.

                      27         Financial Data Schedule

               (b)    Reports on Form 8-K

                      No reports on Form 8-K were filed with the Commission
                      during the three months ended January 31, 2000.

                                       14
<PAGE>


                                    SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                        KEWAUNEE SCIENTIFIC CORPORATION
                                        -------------------------------

                                                 (Registrant)



Date:  March 13, 2000                   By   /s/ D. Michael Parker
                                             --------------------------------
                                             D. Michael Parker
                                             Vice President of Finance
                                             Chief Financial Officer

                                       15

<PAGE>

                                CHANGE OF CONTROL
                              EMPLOYMENT AGREEMENT

         AGREEMENT by and between Kewaunee Scientific Corporation, a Delaware
corporation (the "Company") and William A. Shumaker (the "Executive"), dated as
of the 12th day of November, 1999.

         The Board of Directors of the Company (the "Board") has determined that
it is in the best interests of the Company and its stockholders to assure that
the Company will have the continued dedication of the Executive, notwithstanding
the possibility, threat or occurrence of a Change of Control (as defined below)
of the Company. The Board believes it is imperative to diminish the distraction
of the Executive by virtue of the personal uncertainties and risks created by a
pending or threatened Change of Control and to encourage the Executive's full
attention and dedication to the Company currently and in the event of any
threatened or pending Change of Control, and to provide the Executive with
compensation and benefits arrangements upon a Change of Control which ensure
that the compensation and benefits expectations of the Executive will be
satisfied and which are competitive with those of other corporations. Therefore,
in order to accomplish these objectives the Board has caused the Company to
enter into this Agreement.

NOW, THEREFORE, IT IS HEREBY AGREED AS FOLLOWS:

         1. CHANGE OF CONTROL DATE. (a) The "Change of Control Date" shall mean
the first date during the term of this Agreement on which a Change of Control
(as defined in Section 2) occurs. Anything in this Agreement to the contrary
notwithstanding, if a Change of Control occurs and if the Executive's employment
with the Company is terminated prior to the date on which the Change of Control
occurs, and if it is reasonably demonstrated by the Executive that such
termination of employment (i) was at the request of a third party who has taken
steps reasonably calculated to effect a Change of Control or (ii) otherwise
arose in connection with or in anticipation of a Change of Control, then for all
purposes of this Agreement the "Change of Control Date" shall mean the date
immediately prior to the date of such termination of employment.

                  (b) The term of this Agreement shall commence on the date
hereof and, if no Change of Control Date occurs, shall end on the third
anniversary of the date hereof; subject to extension by mutual agreement of the
parties. If a Change of Control Date occurs on or before the third anniversary
of the date hereof, the term of this Agreement shall end on the later of the
last day of the Employment Period as defined in Section 3 (whether such date is
prior to or after such third anniversary) or the end of the Protection Period as
defined in Section 6.

         2. CHANGE OF CONTROL. For the purpose of this Agreement, a "Change of
Control" shall mean:

<PAGE>

                  (a) The consummation of a transaction in which the Company is
merged, consolidated or reorganized into or with another corporation or other
legal entity, if as a result of such transaction less than 50% of the
outstanding voting securities or other capital interests of the surviving,
resulting or acquiring entity are owned in the aggregate, directly or
indirectly, by the stockholders of the Company immediately prior to such
transaction; or

                  (b) The sale or exchange of more than 50% of the outstanding
shares of common stock of the Company pursuant to an offer made generally for
the acquisition of the common stock of the Company, unless as a result of such
exchange at least 50% of the outstanding voting securities or other capital
interests of the acquiring entity are owned in the aggregate, directly or
indirectly, by the stockholders of the Company immediately prior to such
transaction; or

                  (c) The sale by the Company of all or substantially all of its
business and/or assets to any other corporation or other legal entity, if less
than 50% of the outstanding voting securities or other capital interests of the
acquiring entity are owned in the aggregate, directly or indirectly, by the
persons who were stockholders of the Company immediately before or after such
date; or

                  (d) A change in the membership of the Board such that the
persons who were members of the Board on the date of this Agreement (the
"Original Directors") cease to constitute at least a majority of the Board. For
this purpose, any person whose election, or nomination for election by the
stockholders, is approved by a vote of at least two-thirds of the Original
Directors who are still in office shall be considered an Original Director for
all purposes (including approving the election or nomination of subsequent
directors).

                  (e) Approval by the stockholders of the Company of a complete
liquidation or dissolution of the Company.

         3. EMPLOYMENT PERIOD. The Company hereby agrees to continue the
Executive in its employ, subject to the terms and conditions of this Agreement,
for the period (the "Employment Period")commencing on the Change of Control Date
and ending on the third anniversary of such date, unless sooner terminated
pursuant to Section 5.

         4.       TERMS OF EMPLOYMENT.  (a)  Position and Duties.

                           (i) During the Employment Period, (A) the Executive's
position (including status, offices, titles and reporting requirements),
authority, duties and responsibilities shall be at least commensurate in all
material respects with the most significant of those held, exercised and
assigned to the Executive at any time during the 120-day period immediately
preceding the Change of Control Date and (B) the Executive's services shall be
performed within the Statesville/Charlotte, North Carolina, area, unless he
otherwise consents. Subject to the foregoing, the Executive may be

                                       2
<PAGE>

transferred to the payroll of an entity that is controlled by, or controls,
the Company, and in such event the term "Company" shall be deemed to include
such entity.

                           (ii) During the Employment Period, and excluding any
periods of vacation and sick leave to which the Executive is entitled, the
Executive agrees to devote his attention and time during normal business hours
to the business and affairs of the Company and, to the extent necessary to
discharge the responsibilities assigned to the Executive hereunder, to use the
Executive's reasonable best efforts to perform faithfully and efficiently such
responsibilities. It shall not be a violation of this Agreement for the
Executive to (A) serve on corporate, civic or charitable boards or committees,
(B) deliver lectures, fulfill speaking engagements or teach at educational
institutions and (C) manage personal investments, so long as such activities do
not significantly interfere with the performance of the Executive's
responsibilities as an employee of the Company in accordance with this
Agreement.

                  (b)      Compensation.

                           (i) Base Salary. During the Employment Period, the
Executive shall receive an annual base salary ("Annual Base Salary"), which
shall be paid at a monthly rate, at least equal to twelve times the highest
monthly base salary paid or payable, including any base salary which has been
earned but deferred, to the Executive by the Company in respect of the
twelve-month period immediately preceding the month in which the Change of
Control Date occurs. During the Employment Period, the Annual Base Salary shall
be reviewed no more than 12 months after the last salary increase awarded to the
Executive prior to the Change of Control Date and thereafter at least annually.
Any increase in Annual Base Salary shall not serve to limit or reduce any other
obligation to the Executive under this Agreement. Annual Base Salary shall not
be reduced after any such increase and the term Annual Base Salary as utilized
in this Agreement shall refer to Annual Base Salary as so increased.

                           (ii) Annual Bonus. In addition to Annual Base Salary,
the Executive shall be awarded, for each fiscal year ending during the
Employment Period, an annual bonus (the "Annual Bonus") in cash at least equal
to the average of the Executive's bonus under the Company's annual incentive
bonus plan or any comparable bonus under any predecessor or successor plan, for
the last three full fiscal years prior to the Change of Control Date (annualized
in the event that the Executive was not employed by the Company for the whole of
such fiscal year) (the "Average Annual Bonus"). Each such Annual Bonus shall be
paid no later than the end of the second month of the fiscal year next following
the fiscal year for which the Annual Bonus is awarded, unless the Executive
shall elect to defer the receipt of such Annual Bonus.

                           (iii) Incentive, Savings and Retirement Plans. During
the Employment Period, the Executive shall be entitled to participate in all
incentive, stock option, savings and retirement plans, practices, policies and
programs applicable generally to other peer executives of the Company but in no
event shall such plans, practices, policies and programs provide the Executive
with incentive opportunities,

                                       3
<PAGE>

savings opportunities and retirement benefit opportunities, in each case,
less favorable than the most favorable of those provided by the Company for
the Executive under such plans, practices, policies and programs as in effect
at any time during the 120-day period immediately preceding the Change of
Control Date, except that the foregoing shall not be construed to require the
Company to provide stock options if the Company does not maintain a stock
option plan following the Change of Control, and benefits may be reduced
under a tax qualified plan if substitute benefits are provided under a
nonqualified plan.

                           (iv) Welfare Benefit Plans. During the Employment
Period, the Executive and/or the Executive's family, as the case may be, shall
be eligible for participation in and shall receive all benefits under welfare
benefit plans, practices, policies and programs provided by the Company
(including, without limitation, medical, prescription, dental, disability,
salary continuance, employee life, group life, accidental death and travel
accident insurance plans and programs) to the extent applicable generally to
other peer executives of the Company but in no event shall such plans,
practices, policies and programs provide the Executive with benefits which are
less favorable, in the aggregate, than the most favorable of such plans,
practices, policies and programs in effect for the Executive at any time during
the 120-day period immediately preceding the Change of Control Date.

                           (v) Expenses. During the Employment Period, the
Executive shall be entitled to receive prompt reimbursement for all reasonable
expenses incurred by the Executive in accordance with the policies, practices
and procedures of the Company in effect for the Executive at any time during the
120-day period immediately preceding the Change of Control Date.

                           (vi) Fringe Benefits. During the Employment Period,
the Executive shall be entitled to fringe benefits, in accordance with the most
favorable plans, practices, programs and policies of the Company in effect for
the Executive at any time during the 120-day period immediately preceding the
Change of Control Date.

                           (vii) Office and Support Staff. During the Employment
Period, the Executive shall be entitled to an office or offices of a size and
with furnishings and other appointments, and to personal secretarial and other
assistance, at least equal to those provided to the Executive by the Company at
any time during the 120-day period immediately preceding the Change of Control
Date.

                           (viii) Vacation. During the Employment Period, the
Executive shall be entitled to paid vacations in accordance with the plans,
policies, programs and practices of the Company at least as favorable as those
in effect for the Executive at any time during the 120-day period immediately
preceding the Change of Control Date.

         5. TERMINATION OF EMPLOYMENT. (a) Disability. If the Company determines
in good faith that Disability of the Executive has occurred during the
Employment Period (pursuant to the definition of Disability set forth below), it
may give to the Executive written notice in accordance with Section 11(b) of
this Agreement of its intention to

                                       4
<PAGE>

terminate the Executive's employment. In such event, the Executive's
employment with the Company shall terminate effective on the 30th day after
receipt of such notice by the Executive (the "Disability Effective Date"),
provided that, within the 30 days after such receipt, the Executive shall not
have returned to full-time performance of the Executive's duties. For
purposes of this Agreement, "Disability" shall mean the absence of the
Executive from the Executive's duties with the Company on a full-time basis
for 180 consecutive days as a result of incapacity due to mental or physical
illness which is determined to be total and permanent by a physician selected
by the Company or its insurers and reasonably acceptable to the Executive or
the Executive's legal representative.

                  (b) Cause. The Company may terminate the Executive's
employment during the Employment Period for Cause. For purposes of this
Agreement, "Cause" shall mean:

                           (i) the willful and continued failure of the
Executive to perform substantially the Executive's duties with the Company or
one of its affiliates (other than any such failure resulting from incapacity due
to physical or mental illness), after a written demand for substantial
performance is delivered to the Executive by the Board or the Chief Executive
Officer of the Company which specifically identifies the manner in which the
Board or Chief Executive Officer believes that the Executive has not
substantially performed the Executive's duties, or

                           (ii) the willful engaging by the Executive in illegal
conduct or gross misconduct which is materially and demonstrably injurious to
the Company.

For purposes of this provision, no act or failure to act on the part of the
Executive, shall be considered "willful" unless it is done, or omitted to be
done, by the Executive in bad faith or without reasonable belief that the
Executive's action or omission was in the best interests of the Company. Any
act, or failure to act, based upon authority given pursuant to a resolution duly
adopted by the Board or upon the instructions of the Chief Executive Officer or
a senior officer of the Company or based upon the advice of counsel for the
Company shall be conclusively presumed to be done, or omitted to be done, by the
Executive in good faith and in the best interests of the Company. The cessation
of employment of the Executive shall not be deemed to be for Cause unless and
until there shall have been delivered to the Executive a copy of a resolution
duly adopted by the Board (or the Executive Committee of the Board) at a meeting
of the Board (or Executive Committee) called and held for such purpose (after
reasonable notice is provided to the Executive and the Executive is given an
opportunity, together with counsel, to be heard before the Board (or Executive
Committee)), finding that, in the good faith opinion of the Board (or Executive
Committee), the Executive is guilty of the conduct described in subparagraph (i)
or (ii) above, and specifying the particulars thereof in detail.

                  (c) Good Reason. The Executive's employment may be terminated
by the Executive for Good Reason. For purposes of this Agreement, "Good Reason"
shall mean:

                                       5
<PAGE>

                           (i) the assignment to the Executive of any duties
inconsistent in any material respect with the Executive's position (including
status, offices, titles and reporting requirements), authority, duties or
responsibilities as contemplated by Section 4(a) of this Agreement, or any other
action by the Company which results in a diminution in such position, authority,
duties or responsibilities, excluding for this purpose an isolated and
insubstantial action not taken in bad faith and which is remedied by the Company
promptly after receipt of notice thereof given by the Executive;

                           (ii) any failure by the Company to comply with any of
the provisions of Section 4(b) of this Agreement, other than failure not
occurring in bad faith and which is remedied by the Company promptly after
receipt of notice thereof given by the Executive;

                           (iii) the Company's requiring the Executive to be
based at any office or location other than as provided in Section 4(a)(i)(B)
hereof or the Company's requiring the Executive without his consent to travel on
Company business to a substantially greater extent than required immediately
prior to the Change of Control Date;

                           (iv) any purported termination by the Company of the
Executive's employment otherwise than as expressly permitted by this Agreement;
or

                           (v) any failure by the Company to comply with and
satisfy Section 10(c) of this Agreement.

For purposes of this Section 5(c), any good faith determination of "Good Reason"
made by the Executive shall be conclusive.

                  (d) Notice of Termination. Any termination by the Company for
cause, or by the Executive for Good Reason, shall be communicated by Notice of
Termination to the other party hereto given in accordance with Section 11(b) of
this Agreement. For purposes of this Agreement, a "Notice of Termination" means
a written notice which (i) indicates the specific termination provision in this
Agreement relied upon, (ii) to the extent applicable, sets forth in reasonable
detail the facts and circumstances claimed to provide a basis for termination of
the Executive's employment under the provision so indicated and (iii) if the
Date of Termination (as defined below) is other than the date of receipt of such
notice, specifies the termination date (which date shall be not more than thirty
days after the giving of such notice). The failure by the Executive or the
Company to set forth in the Notice of Termination any fact or circumstance which
contributes to a showing of Good Reason or Cause shall not waive any right of
the Executive or the Company, respectively, hereunder or preclude the Executive
or the Company, respectively, from asserting such fact or circumstance in
enforcing the Executive's or the Company's rights hereunder.

                  (e) Date of Termination. "Date of Termination" means (i) if
the Executive's employment is terminated by the Company for Cause, or by the
Executive

                                       6
<PAGE>

for Good Reason, the date of receipt of the Notice of Termination or any
later date specified therein, as the case may be, (ii) if the Executive's
employment is terminated by the Company other than for Cause or Disability,
the date on which the Company notifies the Executive of such termination and
(iii) if the Executive's employment is terminated by reason of death or
Disability, the date of death of the Executive or the Disability Effective
Date, as the case may be. The Employment Period shall end on the Date of
Termination.

         6. OBLIGATIONS OF THE COMPANY UPON TERMINATION. (a) Termination by
Company Not for Cause; Resignation by Executive for Good Reason. If, during the
Employment Period, the Company shall terminate the Executive's employment other
than for Cause or Disability or the Executive shall terminate employment for
Good Reason, then, in addition to all compensation that has been earned but not
yet paid on the Date of Termination, the Executive shall be entitled to the
following. The amounts to be paid to the Executive pursuant to subparagraphs (i)
through (iv), as applicable, shall be paid in a lump sum in cash within 30 days
after the Date of Termination. All references in subparagraphs (ii) through (iv)
to specific employee benefit plans shall be appropriately adjusted to refer to
any amendments or successors to such plans as in effect on the Date of
Termination, subject to Section 4(b).

                           (i) The Company shall pay to the Executive an amount
equal to either:

                                    A. if the Date of Termination occurs on or
         before the first anniversary of the Change of Control Date, two times
         the sum of the Executive's Annual Base Salary plus his Average Annual
         Bonus; or

                                    B. if the Date of Termination occurs after
         the first anniversary of the Change of Control Date, the sum of the
         Executive's Annual Base Salary plus his Average Annual Bonus.

                           (ii) If the Executive is a participant in the
Kewaunee Scientific Corporation Pension Equalization Plan (the "Equalization
Plan"), his benefit under the Equalization Plan shall be paid in a single lump
sum computed as provided in Section 3.2 of the Equalization Plan regardless of
whether it exceeds $20,000, and shall be increased by an amount equal to the
additional benefit the Executive would have accrued under both the Equalization
Plan and the Re-Established Retirement Plan for Salaried Employees of Kewaunee
Scientific Corporation (the "Retirement Plan") if the Executive's employment had
continued until the end of the Protection Period as defined below, based on the
assumption that the Executive's compensation throughout the Protection Period
would have been that required by Section 4(b)(i) and Section 4(b)(ii). The
provisions of this Section 6(a)(ii) shall be considered an amendment to the
Equalization Plan consented to by the Executive. For purposes of this Agreement,
the "Protection Period" shall mean a period that begins on the Date of
Termination and ends on the second anniversary of the Date of Termination if the
Date of Termination occurs on or before the first anniversary of the Change of
Control Date, or the first

                                       7


<PAGE>

anniversary of the Date of Termination if the Date of Termination occurs
after the first anniversary of the Change of Control Date.

                           (iii) If the Executive is a participant in the
Kewaunee Scientific Corporation Executive Deferred Compensation Plan (the
"Deferred Compensation Plan"), his benefit under the Deferred Compensation Plan
shall be paid in a single lump sum pursuant to Section 5.2 of the Deferred
Compensation Plan regardless of whether he had elected a different form of
benefit, and shall be increased by an amount equal to the additional employer
matching contributions the Executive would have received under both the Deferred
Compensation Plan and the 401K Incentive Savings Plan for Salaried and Hourly
Employees of Kewaunee Scientific Corporation as if the Executive's employment
had continued until the end of the Protection Period, based on the assumption
that the Executive's compensation throughout the Protection Period would have
been that required by Section 4(b)(i) and Section 4(b)(ii), and that the
Executive's would have elected to defer his compensation under both such plans
at the same rate that he had elected immediately prior to the Termination Date.
The provisions of this Section 6(a)(iii) shall be considered an amendment to the
Deferred Compensation Plan consented to by the Executive.

                           (iv) If the Executive is a participant in the
Kewaunee Scientific Corporation Special Employee Benefit Plan (the "SEBP"), he
shall also receive a payment equal to the present value of the vested death
benefit, if any, to which the Executive's beneficiaries would have been entitled
under the SEBP if the Executive's employment had continued until the end of the
Protection Period, based on the assumption that the Executive's compensation
throughout the Protection Period would have been that required by Section
4(b)(i) and Section 4(b)(ii). Such present value shall be determined as if the
death benefit were payable at the end of the Executive's life expectancy,
determined as of the date of payment, and discounted to the date of payment,
using the same mortality and interest rate assumptions used to calculate lump
sum benefits under the Retirement Plan. The provisions of this Section 6(a)(iv)
shall be considered an amendment to the SEBP consented to by the Executive, and
the amount of such payment shall be in full satisfaction of all amounts owed to
the Executive's beneficiaries under the SEBP.

                           (v) During the Protection Period, or such longer
period as may be provided by the terms of the appropriate plan, program,
practice or policy, the Company shall continue benefits to the Executive and/or
the Executive's family at least equal to those which would have been provided to
them in accordance with the plans, programs, practices and policies described in
Section 4(b)(iv) of this Agreement as if the Executive's employment had not been
terminated or, if more favorable to the Executive, as in effect generally at any
time thereafter with respect to other peer executives of the Company and their
families, provided, however, that if the Executive becomes reemployed with
another employer and is eligible to receive medical or other welfare benefits
under another employer-provided plan, the medical and other welfare benefits
described herein shall be secondary to those provided under such other plan
during such applicable period of eligibility, and for purposes of determining
eligibility (but not the time of commencement of benefits) of the Executive for
retiree benefits pursuant to

                                       8
<PAGE>

such plans, practices, programs and policies, the Executive shall be
considered to have remained employed until the end of the Protection Period
and to have retired on the last day of the Protection Period.

                  (b) Death. If the Executive dies during the Employment Period,
this Agreement shall terminate without further obligation to the Executive or
his estate other than the obligation to pay any compensation or benefits that
have been earned but not paid on the Date of Termination, and any
post-termination, life insurance or death benefits that are provided under the
Company's normal benefit plans and policies; provided that the death benefits
payable to the Employee's beneficiaries or estate shall be at least equal to the
most favorable benefits provided by the Company to the estates and beneficiaries
of peer executives of the Company (taking into account differences in
compensation) under such plans, programs, practices and policies relating to
death benefits, if any, as in effect with respect to other peer executives and
their beneficiaries at any time during the 120-day period immediately preceding
the Change of Control Date.

                  (c) Disability. If the Executive's employment shall be
terminated during the Employment Period by reason of the Executive's Disability,
this Agreement shall terminate without further obligation to the Executive other
than the obligation to pay any compensation or benefits that have been earned
but not paid on the Date of Termination, and any post-termination benefits or
disability benefits that are provided under the Company's normal benefit plans
and policies; provided that the disability benefits payable to the Executive
shall be at least equal to the most favorable of those generally provided by the
Company to disabled executives and/or their families in accordance with such
plans, programs, practices and policies relating to disability, if any, as in
effect generally with respect to other peer executives and their families at any
time during the 120-day period immediately preceding the Change of Control Date.

                  (d) Cause; Other than for Good Reason. If the Executive's
employment shall be terminated for Cause during the Employment Period, or if the
Executive shall resign during the Employment Period other than for Good Reason
this Agreement shall terminate without further obligation to the Executive other
than the obligation to pay any compensation or benefits that have been earned
but not paid on the Date of Termination, and any post-termination benefits that
are provided under the Company's normal benefit plans and policies.

         7. NON-EXCLUSIVITY OF RIGHTS. Nothing in this Agreement shall prevent
or limit the Executive's continuing or future participation in any plan,
program, policy or practice (other than any severance pay plan) provided by the
Company and for which the Executive may qualify, nor, subject to Section 11(f),
shall anything herein limit or otherwise affect such rights as the Executive may
have under any contract or agreement with the Company. Amounts which are vested
benefits or which the Executive is otherwise entitled to receive under any plan,
policy, practice or program of or any contract or agreement with the Company at
or subsequent to the Date of Termination shall be payable in accordance with
such plan, policy, practice or program or contract or agreement except as
explicitly modified by this Agreement.

                                       9
<PAGE>

         8. FULL SETTLEMENT; LEGAL FEES. The Company's obligation to make the
payments provided for in this Agreement and otherwise to perform its obligations
hereunder shall not be affected by any set-off, counterclaim, recoupment,
defense or other claim, right or action which the Company may have against the
Executive or others. In no event shall the Executive be obligated to seek other
employment or take any other action by way of mitigation of the amounts payable
to the Executive under any of the provisions of this Agreement and except as
specifically provided in Section 6(a)(iii), such amounts shall not be reduced
whether or not the Executive obtains other employment. The Company agrees to pay
as incurred, to the full extent permitted by law, all legal fees and expense
which the Executive may reasonably incur as a result of any contest by the
Company, the Executive or others of the validity or enforceability of, or
liability under, any provision of this Agreement or any guarantee of performance
thereof (whether such contest is between the Company and the Executive or
between either of them and any third party, and including as a result of any
contest by the Executive about the amount of any payment pursuant to this
Agreement), plus in each case interest on any delayed payment at the applicable
Federal rate provided for in Section 7872(f) (2) (A) of the Internal Revenue
Code of 1986, as amended (the "Code"); provided, however, that if the contest is
between the Executive and the Company, the Company shall be obligated to pay the
Executive's legal fees and expenses if the Executive prevails to any extent in
such contest.

         9. CONFIDENTIAL INFORMATION. The Executive shall hold in a fiduciary
capacity for the benefit of the Company all secret or confidential information,
knowledge or data relating to the Company, and their respective businesses,
which shall have been obtained by the Executive during the Executive's
employment by the Company and which shall not be or become public knowledge
(other than by acts by the Executive or representatives of the Executive in
violation of this Agreement). After termination of the Executive's employment
with the Company, the Executive shall not, without the prior written consent of
the Company or as may otherwise be required by law or legal process, communicate
or divulge any such information, knowledge or data to anyone other than the
Company and those designated by it. In no event shall an asserted violation of
the provisions of this Section 9 constitute a basis for deferring or withholding
any amounts otherwise payable to the Executive under this Agreement.

         10. SUCCESSORS. (a) This Agreement is personal to the Executive and
without the prior written consent of the Company shall not be assignable by the
Executive otherwise than by will or the laws of descent and distribution. This
Agreement shall inure to the benefit of and be enforceable by the Executive's
legal representatives.

                  (b) This Agreement shall inure to the benefit of and be
binding upon the Company and its successors and assigns.

                  (c) The Company will require any successor (whether direct or
indirect, by purchase, merger, consolidation or otherwise) to all or
substantially all of the business and/or assets of the Company to assume
expressly and agree to perform this Agreement in the same manner and to the same
extent that the Company would be required to perform it if no such succession
had taken place. As used in this

                                       10
<PAGE>

Agreement, "Company" shall mean the Company as hereinbefore defined and any
successor to its business and/or assets as aforesaid which assumes and agrees
to perform this Agreement by operation of law, or otherwise.

         11. MISCELLANEOUS. (a) This Agreement shall be governed by and
construed in accordance with the laws of the State of North Carolina without
reference to principles of conflict of laws. The captions of this Agreement are
not part of the provisions hereof and shall have no force or effect. This
Agreement may not be amended or modified otherwise than by a written agreement
executed by the parties hereto or their respective successors and legal
representatives.

                  (b) All notices and other communications hereunder shall be in
writing and shall be given by hand delivery to the other party or by registered
or certified mail, return receipt requested, postage prepaid, addressed as
follows:

                  If to the Executive:    William A. Shumaker
                                          130 Pin Oak Lane
                                          Mooresville, NC 28115

                  If to the Company:      Kewaunee Scientific Corporation
                                          2700 West Front Street
                                          Statesville, NC 28677
                                          Attention:  Chief Executive Officer

or to such other address as either party shall have furnished to the other in
writing in accordance herewith. Notice and communications shall be effective
when actually received by the addressee.

                  (c) The invalidity or unenforceability of any provision of
this Agreement shall not affect the validity or enforceability of any other
provision of this Agreement.

                  (d) The Company may withhold from any amounts payable under
this Agreement such Federal, state, local or foreign taxes as shall be required
to be withheld pursuant to any applicable law or regulation.

                  (e) The Executive's or the Company's failure to insist upon
strict compliance with any provision hereof or any other provision of this
Agreement or the failure to assert any right the Executive or the Company may
have hereunder, including, without limitation, the right of the Executive to
terminate employment for Good Reason pursuant to Section 5(c) (i)-(v) of this
Agreement, shall not be deemed to be a waiver of such provision or right or any
other provision or right of this Agreement.

                  (f) The Executive and the Company acknowledge that, except as
may otherwise be provided under any other written agreement between the
Executive and the Company, the employment of the Executive by the Company is "at
will" and, prior to the Change of Control Date, the Executive's employment may
be terminated by either the Executive or the Company at any time prior to the
Change of Control Date, in which case the Executive shall have no further rights
under this Agreement. From and after

                                       11
<PAGE>

the Change of Control Date this Agreement shall supersede any other agreement
between the parties with respect to the subject matter hereof.

         IN WITNESS WHEREOF, the Executive has hereunto set the Executive's hand
and, pursuant to the authorization from its Board of Directors, the Company has
caused this Agreement to be executed in its name on its behalf, all as of the
day and year first above written.

                                        /s/ William A. Shumaker
                                        --------------------------------
                                              (Executive)

                                        KEWAUNEE SCIENTIFIC CORPORATION

                                        By:         /s/ Eli Manchester, Jr.
                                           ------------------------------------
                                       Its:        Chairman and CEO
                                           ------------------------------------

                                       12

<PAGE>

                                CHANGE OF CONTROL
                              EMPLOYMENT AGREEMENT

         AGREEMENT by and between Kewaunee Scientific Corporation, a Delaware
corporation (the "Company") and D. Michael Parker (the "Executive"), dated as
of the 12th day of November, 1999.

         The Board of Directors of the Company (the "Board") has determined that
it is in the best interests of the Company and its stockholders to assure that
the Company will have the continued dedication of the Executive, notwithstanding
the possibility, threat or occurrence of a Change of Control (as defined below)
of the Company. The Board believes it is imperative to diminish the distraction
of the Executive by virtue of the personal uncertainties and risks created by a
pending or threatened Change of Control and to encourage the Executive's full
attention and dedication to the Company currently and in the event of any
threatened or pending Change of Control, and to provide the Executive with
compensation and benefits arrangements upon a Change of Control which ensure
that the compensation and benefits expectations of the Executive will be
satisfied and which are competitive with those of other corporations. Therefore,
in order to accomplish these objectives the Board has caused the Company to
enter into this Agreement.

NOW, THEREFORE, IT IS HEREBY AGREED AS FOLLOWS:

         1. CHANGE OF CONTROL DATE. (a) The "Change of Control Date" shall mean
the first date during the term of this Agreement on which a Change of Control
(as defined in Section 2) occurs. Anything in this Agreement to the contrary
notwithstanding, if a Change of Control occurs and if the Executive's employment
with the Company is terminated prior to the date on which the Change of Control
occurs, and if it is reasonably demonstrated by the Executive that such
termination of employment (i) was at the request of a third party who has taken
steps reasonably calculated to effect a Change of Control or (ii) otherwise
arose in connection with or in anticipation of a Change of Control, then for all
purposes of this Agreement the "Change of Control Date" shall mean the date
immediately prior to the date of such termination of employment.

                  (b) The term of this Agreement shall commence on the date
hereof and, if no Change of Control Date occurs, shall end on the third
anniversary of the date hereof; subject to extension by mutual agreement of the
parties. If a Change of Control Date occurs on or before the third anniversary
of the date hereof, the term of this Agreement shall end on the later of the
last day of the Employment Period as defined in Section 3 (whether such date is
prior to or after such third anniversary) or the end of the Protection Period as
defined in Section 6.

         2. CHANGE OF CONTROL. For the purpose of this Agreement, a "Change of
Control" shall mean:

<PAGE>

                  (a) The consummation of a transaction in which the Company is
merged, consolidated or reorganized into or with another corporation or other
legal entity, if as a result of such transaction less than 50% of the
outstanding voting securities or other capital interests of the surviving,
resulting or acquiring entity are owned in the aggregate, directly or
indirectly, by the stockholders of the Company immediately prior to such
transaction; or

                  (b) The sale or exchange of more than 50% of the outstanding
shares of common stock of the Company pursuant to an offer made generally for
the acquisition of the common stock of the Company, unless as a result of such
exchange at least 50% of the outstanding voting securities or other capital
interests of the acquiring entity are owned in the aggregate, directly or
indirectly, by the stockholders of the Company immediately prior to such
transaction; or

                  (c) The sale by the Company of all or substantially all of its
business and/or assets to any other corporation or other legal entity, if less
than 50% of the outstanding voting securities or other capital interests of the
acquiring entity are owned in the aggregate, directly or indirectly, by the
persons who were stockholders of the Company immediately before or after such
date; or

                  (d) A change in the membership of the Board such that the
persons who were members of the Board on the date of this Agreement (the
"Original Directors") cease to constitute at least a majority of the Board. For
this purpose, any person whose election, or nomination for election by the
stockholders, is approved by a vote of at least two-thirds of the Original
Directors who are still in office shall be considered an Original Director for
all purposes (including approving the election or nomination of subsequent
directors).

                  (e) Approval by the stockholders of the Company of a complete
liquidation or dissolution of the Company.

         3. EMPLOYMENT PERIOD. The Company hereby agrees to continue the
Executive in its employ, subject to the terms and conditions of this Agreement,
for the period (the "Employment Period")commencing on the Change of Control Date
and ending on the third anniversary of such date, unless sooner terminated
pursuant to Section 5.

         4.       TERMS OF EMPLOYMENT.  (a)  Position and Duties.

                           (i) During the Employment Period, (A) the Executive's
position (including status, offices, titles and reporting requirements),
authority, duties and responsibilities shall be at least commensurate in all
material respects with the most significant of those held, exercised and
assigned to the Executive at any time during the 120-day period immediately
preceding the Change of Control Date and (B) the Executive's services shall be
performed within the Statesville/Charlotte, North Carolina, area, unless he
otherwise consents. Subject to the foregoing, the Executive may be

                                       2
<PAGE>

transferred to the payroll of an entity that is controlled by, or controls,
the Company, and in such event the term "Company" shall be deemed to include
such entity.

                           (ii) During the Employment Period, and excluding any
periods of vacation and sick leave to which the Executive is entitled, the
Executive agrees to devote his attention and time during normal business hours
to the business and affairs of the Company and, to the extent necessary to
discharge the responsibilities assigned to the Executive hereunder, to use the
Executive's reasonable best efforts to perform faithfully and efficiently such
responsibilities. It shall not be a violation of this Agreement for the
Executive to (A) serve on corporate, civic or charitable boards or committees,
(B) deliver lectures, fulfill speaking engagements or teach at educational
institutions and (C) manage personal investments, so long as such activities do
not significantly interfere with the performance of the Executive's
responsibilities as an employee of the Company in accordance with this
Agreement.

                  (b)      Compensation.

                           (i) Base Salary. During the Employment Period, the
Executive shall receive an annual base salary ("Annual Base Salary"), which
shall be paid at a monthly rate, at least equal to twelve times the highest
monthly base salary paid or payable, including any base salary which has been
earned but deferred, to the Executive by the Company in respect of the
twelve-month period immediately preceding the month in which the Change of
Control Date occurs. During the Employment Period, the Annual Base Salary shall
be reviewed no more than 12 months after the last salary increase awarded to the
Executive prior to the Change of Control Date and thereafter at least annually.
Any increase in Annual Base Salary shall not serve to limit or reduce any other
obligation to the Executive under this Agreement. Annual Base Salary shall not
be reduced after any such increase and the term Annual Base Salary as utilized
in this Agreement shall refer to Annual Base Salary as so increased.

                           (ii) Annual Bonus. In addition to Annual Base Salary,
the Executive shall be awarded, for each fiscal year ending during the
Employment Period, an annual bonus (the "Annual Bonus") in cash at least equal
to the average of the Executive's bonus under the Company's annual incentive
bonus plan or any comparable bonus under any predecessor or successor plan, for
the last three full fiscal years prior to the Change of Control Date (annualized
in the event that the Executive was not employed by the Company for the whole of
such fiscal year) (the "Average Annual Bonus"). Each such Annual Bonus shall be
paid no later than the end of the second month of the fiscal year next following
the fiscal year for which the Annual Bonus is awarded, unless the Executive
shall elect to defer the receipt of such Annual Bonus.

                           (iii) Incentive, Savings and Retirement Plans. During
the Employment Period, the Executive shall be entitled to participate in all
incentive, stock option, savings and retirement plans, practices, policies and
programs applicable generally to other peer executives of the Company but in no
event shall such plans, practices, policies and programs provide the Executive
with incentive opportunities,

                                       3
<PAGE>

savings opportunities and retirement benefit opportunities, in each case,
less favorable than the most favorable of those provided by the Company for
the Executive under such plans, practices, policies and programs as in effect
at any time during the 120-day period immediately preceding the Change of
Control Date, except that the foregoing shall not be construed to require the
Company to provide stock options if the Company does not maintain a stock
option plan following the Change of Control, and benefits may be reduced
under a tax qualified plan if substitute benefits are provided under a
nonqualified plan.

                           (iv) Welfare Benefit Plans. During the Employment
Period, the Executive and/or the Executive's family, as the case may be, shall
be eligible for participation in and shall receive all benefits under welfare
benefit plans, practices, policies and programs provided by the Company
(including, without limitation, medical, prescription, dental, disability,
salary continuance, employee life, group life, accidental death and travel
accident insurance plans and programs) to the extent applicable generally to
other peer executives of the Company but in no event shall such plans,
practices, policies and programs provide the Executive with benefits which are
less favorable, in the aggregate, than the most favorable of such plans,
practices, policies and programs in effect for the Executive at any time during
the 120-day period immediately preceding the Change of Control Date.

                           (v) Expenses. During the Employment Period, the
Executive shall be entitled to receive prompt reimbursement for all reasonable
expenses incurred by the Executive in accordance with the policies, practices
and procedures of the Company in effect for the Executive at any time during the
120-day period immediately preceding the Change of Control Date.

                           (vi) Fringe Benefits. During the Employment Period,
the Executive shall be entitled to fringe benefits, in accordance with the most
favorable plans, practices, programs and policies of the Company in effect for
the Executive at any time during the 120-day period immediately preceding the
Change of Control Date.

                           (vii) Office and Support Staff. During the Employment
Period, the Executive shall be entitled to an office or offices of a size and
with furnishings and other appointments, and to personal secretarial and other
assistance, at least equal to those provided to the Executive by the Company at
any time during the 120-day period immediately preceding the Change of Control
Date.

                           (viii) Vacation. During the Employment Period, the
Executive shall be entitled to paid vacations in accordance with the plans,
policies, programs and practices of the Company at least as favorable as those
in effect for the Executive at any time during the 120-day period immediately
preceding the Change of Control Date.

         5. TERMINATION OF EMPLOYMENT. (a) Disability. If the Company determines
in good faith that Disability of the Executive has occurred during the
Employment Period (pursuant to the definition of Disability set forth below), it
may give to the Executive written notice in accordance with Section 11(b) of
this Agreement of its intention to

                                       4
<PAGE>

terminate the Executive's employment. In such event, the Executive's
employment with the Company shall terminate effective on the 30th day after
receipt of such notice by the Executive (the "Disability Effective Date"),
provided that, within the 30 days after such receipt, the Executive shall not
have returned to full-time performance of the Executive's duties. For
purposes of this Agreement, "Disability" shall mean the absence of the
Executive from the Executive's duties with the Company on a full-time basis
for 180 consecutive days as a result of incapacity due to mental or physical
illness which is determined to be total and permanent by a physician selected
by the Company or its insurers and reasonably acceptable to the Executive or
the Executive's legal representative.

                  (b) Cause. The Company may terminate the Executive's
employment during the Employment Period for Cause. For purposes of this
Agreement, "Cause" shall mean:

                           (i) the willful and continued failure of the
Executive to perform substantially the Executive's duties with the Company or
one of its affiliates (other than any such failure resulting from incapacity due
to physical or mental illness), after a written demand for substantial
performance is delivered to the Executive by the Board or the Chief Executive
Officer of the Company which specifically identifies the manner in which the
Board or Chief Executive Officer believes that the Executive has not
substantially performed the Executive's duties, or

                           (ii) the willful engaging by the Executive in illegal
conduct or gross misconduct which is materially and demonstrably injurious to
the Company.

For purposes of this provision, no act or failure to act on the part of the
Executive, shall be considered "willful" unless it is done, or omitted to be
done, by the Executive in bad faith or without reasonable belief that the
Executive's action or omission was in the best interests of the Company. Any
act, or failure to act, based upon authority given pursuant to a resolution duly
adopted by the Board or upon the instructions of the Chief Executive Officer or
a senior officer of the Company or based upon the advice of counsel for the
Company shall be conclusively presumed to be done, or omitted to be done, by the
Executive in good faith and in the best interests of the Company. The cessation
of employment of the Executive shall not be deemed to be for Cause unless and
until there shall have been delivered to the Executive a copy of a resolution
duly adopted by the Board (or the Executive Committee of the Board) at a meeting
of the Board (or Executive Committee) called and held for such purpose (after
reasonable notice is provided to the Executive and the Executive is given an
opportunity, together with counsel, to be heard before the Board (or Executive
Committee)), finding that, in the good faith opinion of the Board (or Executive
Committee), the Executive is guilty of the conduct described in subparagraph (i)
or (ii) above, and specifying the particulars thereof in detail.

                  (c) Good Reason. The Executive's employment may be terminated
by the Executive for Good Reason. For purposes of this Agreement, "Good Reason"
shall mean:

                                       5
<PAGE>

                           (i) the assignment to the Executive of any duties
inconsistent in any material respect with the Executive's position (including
status, offices, titles and reporting requirements), authority, duties or
responsibilities as contemplated by Section 4(a) of this Agreement, or any other
action by the Company which results in a diminution in such position, authority,
duties or responsibilities, excluding for this purpose an isolated and
insubstantial action not taken in bad faith and which is remedied by the Company
promptly after receipt of notice thereof given by the Executive;

                           (ii) any failure by the Company to comply with any of
the provisions of Section 4(b) of this Agreement, other than failure not
occurring in bad faith and which is remedied by the Company promptly after
receipt of notice thereof given by the Executive;

                           (iii) the Company's requiring the Executive to be
based at any office or location other than as provided in Section 4(a)(i)(B)
hereof or the Company's requiring the Executive without his consent to travel on
Company business to a substantially greater extent than required immediately
prior to the Change of Control Date;

                           (iv) any purported termination by the Company of the
Executive's employment otherwise than as expressly permitted by this Agreement;
or

                           (v) any failure by the Company to comply with and
satisfy Section 10(c) of this Agreement.

For purposes of this Section 5(c), any good faith determination of "Good Reason"
made by the Executive shall be conclusive.

                  (d) Notice of Termination. Any termination by the Company for
cause, or by the Executive for Good Reason, shall be communicated by Notice of
Termination to the other party hereto given in accordance with Section 11(b) of
this Agreement. For purposes of this Agreement, a "Notice of Termination" means
a written notice which (i) indicates the specific termination provision in this
Agreement relied upon, (ii) to the extent applicable, sets forth in reasonable
detail the facts and circumstances claimed to provide a basis for termination of
the Executive's employment under the provision so indicated and (iii) if the
Date of Termination (as defined below) is other than the date of receipt of such
notice, specifies the termination date (which date shall be not more than thirty
days after the giving of such notice). The failure by the Executive or the
Company to set forth in the Notice of Termination any fact or circumstance which
contributes to a showing of Good Reason or Cause shall not waive any right of
the Executive or the Company, respectively, hereunder or preclude the Executive
or the Company, respectively, from asserting such fact or circumstance in
enforcing the Executive's or the Company's rights hereunder.

                  (e) Date of Termination. "Date of Termination" means (i) if
the Executive's employment is terminated by the Company for Cause, or by the
Executive

                                       6
<PAGE>

for Good Reason, the date of receipt of the Notice of Termination or any
later date specified therein, as the case may be, (ii) if the Executive's
employment is terminated by the Company other than for Cause or Disability,
the date on which the Company notifies the Executive of such termination and
(iii) if the Executive's employment is terminated by reason of death or
Disability, the date of death of the Executive or the Disability Effective
Date, as the case may be. The Employment Period shall end on the Date of
Termination.

         6. OBLIGATIONS OF THE COMPANY UPON TERMINATION. (a) Termination by
Company Not for Cause; Resignation by Executive for Good Reason. If, during the
Employment Period, the Company shall terminate the Executive's employment other
than for Cause or Disability or the Executive shall terminate employment for
Good Reason, then, in addition to all compensation that has been earned but not
yet paid on the Date of Termination, the Executive shall be entitled to the
following. The amounts to be paid to the Executive pursuant to subparagraphs (i)
through (iv), as applicable, shall be paid in a lump sum in cash within 30 days
after the Date of Termination. All references in subparagraphs (ii) through (iv)
to specific employee benefit plans shall be appropriately adjusted to refer to
any amendments or successors to such plans as in effect on the Date of
Termination, subject to Section 4(b).

                           (i) The Company shall pay to the Executive an amount
equal to either:

                                    A. if the Date of Termination occurs on or
         before the first anniversary of the Change of Control Date, two times
         the sum of the Executive's Annual Base Salary plus his Average Annual
         Bonus; or

                                    B. if the Date of Termination occurs after
         the first anniversary of the Change of Control Date, the sum of the
         Executive's Annual Base Salary plus his Average Annual Bonus.

                           (ii) If the Executive is a participant in the
Kewaunee Scientific Corporation Pension Equalization Plan (the "Equalization
Plan"), his benefit under the Equalization Plan shall be paid in a single lump
sum computed as provided in Section 3.2 of the Equalization Plan regardless of
whether it exceeds $20,000, and shall be increased by an amount equal to the
additional benefit the Executive would have accrued under both the Equalization
Plan and the Re-Established Retirement Plan for Salaried Employees of Kewaunee
Scientific Corporation (the "Retirement Plan") if the Executive's employment had
continued until the end of the Protection Period as defined below, based on the
assumption that the Executive's compensation throughout the Protection Period
would have been that required by Section 4(b)(i) and Section 4(b)(ii). The
provisions of this Section 6(a)(ii) shall be considered an amendment to the
Equalization Plan consented to by the Executive. For purposes of this Agreement,
the "Protection Period" shall mean a period that begins on the Date of
Termination and ends on the second anniversary of the Date of Termination if the
Date of Termination occurs on or before the first anniversary of the Change of
Control Date, or the first

                                       7


<PAGE>

anniversary of the Date of Termination if the Date of Termination occurs
after the first anniversary of the Change of Control Date.

                           (iii) If the Executive is a participant in the
Kewaunee Scientific Corporation Executive Deferred Compensation Plan (the
"Deferred Compensation Plan"), his benefit under the Deferred Compensation Plan
shall be paid in a single lump sum pursuant to Section 5.2 of the Deferred
Compensation Plan regardless of whether he had elected a different form of
benefit, and shall be increased by an amount equal to the additional employer
matching contributions the Executive would have received under both the Deferred
Compensation Plan and the 401K Incentive Savings Plan for Salaried and Hourly
Employees of Kewaunee Scientific Corporation as if the Executive's employment
had continued until the end of the Protection Period, based on the assumption
that the Executive's compensation throughout the Protection Period would have
been that required by Section 4(b)(i) and Section 4(b)(ii), and that the
Executive's would have elected to defer his compensation under both such plans
at the same rate that he had elected immediately prior to the Termination Date.
The provisions of this Section 6(a)(iii) shall be considered an amendment to the
Deferred Compensation Plan consented to by the Executive.

                           (iv) If the Executive is a participant in the
Kewaunee Scientific Corporation Special Employee Benefit Plan (the "SEBP"), he
shall also receive a payment equal to the present value of the vested death
benefit, if any, to which the Executive's beneficiaries would have been entitled
under the SEBP if the Executive's employment had continued until the end of the
Protection Period, based on the assumption that the Executive's compensation
throughout the Protection Period would have been that required by Section
4(b)(i) and Section 4(b)(ii). Such present value shall be determined as if the
death benefit were payable at the end of the Executive's life expectancy,
determined as of the date of payment, and discounted to the date of payment,
using the same mortality and interest rate assumptions used to calculate lump
sum benefits under the Retirement Plan. The provisions of this Section 6(a)(iv)
shall be considered an amendment to the SEBP consented to by the Executive, and
the amount of such payment shall be in full satisfaction of all amounts owed to
the Executive's beneficiaries under the SEBP.

                           (v) During the Protection Period, or such longer
period as may be provided by the terms of the appropriate plan, program,
practice or policy, the Company shall continue benefits to the Executive and/or
the Executive's family at least equal to those which would have been provided to
them in accordance with the plans, programs, practices and policies described in
Section 4(b)(iv) of this Agreement as if the Executive's employment had not been
terminated or, if more favorable to the Executive, as in effect generally at any
time thereafter with respect to other peer executives of the Company and their
families, provided, however, that if the Executive becomes reemployed with
another employer and is eligible to receive medical or other welfare benefits
under another employer-provided plan, the medical and other welfare benefits
described herein shall be secondary to those provided under such other plan
during such applicable period of eligibility, and for purposes of determining
eligibility (but not the time of commencement of benefits) of the Executive for
retiree benefits pursuant to

                                       8
<PAGE>

such plans, practices, programs and policies, the Executive shall be
considered to have remained employed until the end of the Protection Period
and to have retired on the last day of the Protection Period.

                  (b) Death. If the Executive dies during the Employment Period,
this Agreement shall terminate without further obligation to the Executive or
his estate other than the obligation to pay any compensation or benefits that
have been earned but not paid on the Date of Termination, and any
post-termination, life insurance or death benefits that are provided under the
Company's normal benefit plans and policies; provided that the death benefits
payable to the Employee's beneficiaries or estate shall be at least equal to the
most favorable benefits provided by the Company to the estates and beneficiaries
of peer executives of the Company (taking into account differences in
compensation) under such plans, programs, practices and policies relating to
death benefits, if any, as in effect with respect to other peer executives and
their beneficiaries at any time during the 120-day period immediately preceding
the Change of Control Date.

                  (c) Disability. If the Executive's employment shall be
terminated during the Employment Period by reason of the Executive's Disability,
this Agreement shall terminate without further obligation to the Executive other
than the obligation to pay any compensation or benefits that have been earned
but not paid on the Date of Termination, and any post-termination benefits or
disability benefits that are provided under the Company's normal benefit plans
and policies; provided that the disability benefits payable to the Executive
shall be at least equal to the most favorable of those generally provided by the
Company to disabled executives and/or their families in accordance with such
plans, programs, practices and policies relating to disability, if any, as in
effect generally with respect to other peer executives and their families at any
time during the 120-day period immediately preceding the Change of Control Date.

                  (d) Cause; Other than for Good Reason. If the Executive's
employment shall be terminated for Cause during the Employment Period, or if the
Executive shall resign during the Employment Period other than for Good Reason
this Agreement shall terminate without further obligation to the Executive other
than the obligation to pay any compensation or benefits that have been earned
but not paid on the Date of Termination, and any post-termination benefits that
are provided under the Company's normal benefit plans and policies.

         7. NON-EXCLUSIVITY OF RIGHTS. Nothing in this Agreement shall prevent
or limit the Executive's continuing or future participation in any plan,
program, policy or practice (other than any severance pay plan) provided by the
Company and for which the Executive may qualify, nor, subject to Section 11(f),
shall anything herein limit or otherwise affect such rights as the Executive may
have under any contract or agreement with the Company. Amounts which are vested
benefits or which the Executive is otherwise entitled to receive under any plan,
policy, practice or program of or any contract or agreement with the Company at
or subsequent to the Date of Termination shall be payable in accordance with
such plan, policy, practice or program or contract or agreement except as
explicitly modified by this Agreement.

                                       9
<PAGE>

         8. FULL SETTLEMENT; LEGAL FEES. The Company's obligation to make the
payments provided for in this Agreement and otherwise to perform its obligations
hereunder shall not be affected by any set-off, counterclaim, recoupment,
defense or other claim, right or action which the Company may have against the
Executive or others. In no event shall the Executive be obligated to seek other
employment or take any other action by way of mitigation of the amounts payable
to the Executive under any of the provisions of this Agreement and except as
specifically provided in Section 6(a)(iii), such amounts shall not be reduced
whether or not the Executive obtains other employment. The Company agrees to pay
as incurred, to the full extent permitted by law, all legal fees and expense
which the Executive may reasonably incur as a result of any contest by the
Company, the Executive or others of the validity or enforceability of, or
liability under, any provision of this Agreement or any guarantee of performance
thereof (whether such contest is between the Company and the Executive or
between either of them and any third party, and including as a result of any
contest by the Executive about the amount of any payment pursuant to this
Agreement), plus in each case interest on any delayed payment at the applicable
Federal rate provided for in Section 7872(f) (2) (A) of the Internal Revenue
Code of 1986, as amended (the "Code"); provided, however, that if the contest is
between the Executive and the Company, the Company shall be obligated to pay the
Executive's legal fees and expenses if the Executive prevails to any extent in
such contest.

         9. CONFIDENTIAL INFORMATION. The Executive shall hold in a fiduciary
capacity for the benefit of the Company all secret or confidential information,
knowledge or data relating to the Company, and their respective businesses,
which shall have been obtained by the Executive during the Executive's
employment by the Company and which shall not be or become public knowledge
(other than by acts by the Executive or representatives of the Executive in
violation of this Agreement). After termination of the Executive's employment
with the Company, the Executive shall not, without the prior written consent of
the Company or as may otherwise be required by law or legal process, communicate
or divulge any such information, knowledge or data to anyone other than the
Company and those designated by it. In no event shall an asserted violation of
the provisions of this Section 9 constitute a basis for deferring or withholding
any amounts otherwise payable to the Executive under this Agreement.

         10. SUCCESSORS. (a) This Agreement is personal to the Executive and
without the prior written consent of the Company shall not be assignable by the
Executive otherwise than by will or the laws of descent and distribution. This
Agreement shall inure to the benefit of and be enforceable by the Executive's
legal representatives.

                  (b) This Agreement shall inure to the benefit of and be
binding upon the Company and its successors and assigns.

                  (c) The Company will require any successor (whether direct or
indirect, by purchase, merger, consolidation or otherwise) to all or
substantially all of the business and/or assets of the Company to assume
expressly and agree to perform this Agreement in the same manner and to the same
extent that the Company would be required to perform it if no such succession
had taken place. As used in this

                                       10
<PAGE>

Agreement, "Company" shall mean the Company as hereinbefore defined and any
successor to its business and/or assets as aforesaid which assumes and agrees
to perform this Agreement by operation of law, or otherwise.

         11. MISCELLANEOUS. (a) This Agreement shall be governed by and
construed in accordance with the laws of the State of North Carolina without
reference to principles of conflict of laws. The captions of this Agreement are
not part of the provisions hereof and shall have no force or effect. This
Agreement may not be amended or modified otherwise than by a written agreement
executed by the parties hereto or their respective successors and legal
representatives.

                  (b) All notices and other communications hereunder shall be in
writing and shall be given by hand delivery to the other party or by registered
or certified mail, return receipt requested, postage prepaid, addressed as
follows:

                  If to the Executive:    D. Michael Parker
                                          140 Colony Drive
                                          Mooresville, NC 28115

                  If to the Company:      Kewaunee Scientific Corporation
                                          2700 West Front Street
                                          Statesville, NC 28677
                                          Attention:  Chief Executive Officer

or to such other address as either party shall have furnished to the other in
writing in accordance herewith. Notice and communications shall be effective
when actually received by the addressee.

                  (c) The invalidity or unenforceability of any provision of
this Agreement shall not affect the validity or enforceability of any other
provision of this Agreement.

                  (d) The Company may withhold from any amounts payable under
this Agreement such Federal, state, local or foreign taxes as shall be required
to be withheld pursuant to any applicable law or regulation.

                  (e) The Executive's or the Company's failure to insist upon
strict compliance with any provision hereof or any other provision of this
Agreement or the failure to assert any right the Executive or the Company may
have hereunder, including, without limitation, the right of the Executive to
terminate employment for Good Reason pursuant to Section 5(c) (i)-(v) of this
Agreement, shall not be deemed to be a waiver of such provision or right or any
other provision or right of this Agreement.

                  (f) The Executive and the Company acknowledge that, except as
may otherwise be provided under any other written agreement between the
Executive and the Company, the employment of the Executive by the Company is "at
will" and, prior to the Change of Control Date, the Executive's employment may
be terminated by either the Executive or the Company at any time prior to the
Change of Control Date, in which case the Executive shall have no further rights
under this Agreement. From and after

                                       11
<PAGE>

the Change of Control Date this Agreement shall supersede any other agreement
between the parties with respect to the subject matter hereof.

         IN WITNESS WHEREOF, the Executive has hereunto set the Executive's hand
and, pursuant to the authorization from its Board of Directors, the Company has
caused this Agreement to be executed in its name on its behalf, all as of the
day and year first above written.

                                        /s/ D. Michael Parker
                                        --------------------------------
                                              (Executive)

                                        KEWAUNEE SCIENTIFIC CORPORATION

                                        By:         /s/ Eli Manchester, Jr.
                                           ------------------------------------
                                       Its:        Chairman and CEO
                                           ------------------------------------

                                       12

<PAGE>

                                CHANGE OF CONTROL
                              EMPLOYMENT AGREEMENT

         AGREEMENT by and between Kewaunee Scientific Corporation, a Delaware
corporation (the "Company") and James J. Rossi (the "Executive"), dated as of
the 12th day of November, 1999.

         The Board of Directors of the Company (the "Board") has determined that
it is in the best interests of the Company and its stockholders to assure that
the Company will have the continued dedication of the Executive, notwithstanding
the possibility, threat or occurrence of a Change of Control (as defined below)
of the Company. The Board believes it is imperative to diminish the distraction
of the Executive by virtue of the personal uncertainties and risks created by a
pending or threatened Change of Control and to encourage the Executive's full
attention and dedication to the Company currently and in the event of any
threatened or pending Change of Control, and to provide the Executive with
compensation and benefits arrangements upon a Change of Control which ensure
that the compensation and benefits expectations of the Executive will be
satisfied and which are competitive with those of other corporations. Therefore,
in order to accomplish these objectives the Board has caused the Company to
enter into this Agreement.

NOW, THEREFORE, IT IS HEREBY AGREED AS FOLLOWS:

         1. CHANGE OF CONTROL DATE. (a) The "Change of Control Date" shall mean
the first date during the term of this Agreement on which a Change of Control
(as defined in Section 2) occurs. Anything in this Agreement to the contrary
notwithstanding, if a Change of Control occurs and if the Executive's employment
with the Company is terminated prior to the date on which the Change of Control
occurs, and if it is reasonably demonstrated by the Executive that such
termination of employment (i) was at the request of a third party who has taken
steps reasonably calculated to effect a Change of Control or (ii) otherwise
arose in connection with or in anticipation of a Change of Control, then for all
purposes of this Agreement the "Change of Control Date" shall mean the date
immediately prior to the date of such termination of employment.

                  (b) The term of this Agreement shall commence on the date
hereof and, if no Change of Control Date occurs, shall end on the third
anniversary of the date hereof; subject to extension by mutual agreement of the
parties. If a Change of Control Date occurs on or before the third anniversary
of the date hereof, the term of this Agreement shall end on the later of the
last day of the Employment Period as defined in Section 3 (whether such date is
prior to or after such third anniversary) or the end of the Protection Period as
defined in Section 6.

         2. CHANGE OF CONTROL. For the purpose of this Agreement, a "Change of
Control" shall mean:

<PAGE>

                  (a) The consummation of a transaction in which the Company is
merged, consolidated or reorganized into or with another corporation or other
legal entity, if as a result of such transaction less than 50% of the
outstanding voting securities or other capital interests of the surviving,
resulting or acquiring entity are owned in the aggregate, directly or
indirectly, by the stockholders of the Company immediately prior to such
transaction; or

                  (b) The sale or exchange of more than 50% of the outstanding
shares of common stock of the Company pursuant to an offer made generally for
the acquisition of the common stock of the Company, unless as a result of such
exchange at least 50% of the outstanding voting securities or other capital
interests of the acquiring entity are owned in the aggregate, directly or
indirectly, by the stockholders of the Company immediately prior to such
transaction; or

                  (c) The sale by the Company of all or substantially all of its
business and/or assets to any other corporation or other legal entity, if less
than 50% of the outstanding voting securities or other capital interests of the
acquiring entity are owned in the aggregate, directly or indirectly, by the
persons who were stockholders of the Company immediately before or after such
date; or

                  (d) A change in the membership of the Board such that the
persons who were members of the Board on the date of this Agreement (the
"Original Directors") cease to constitute at least a majority of the Board. For
this purpose, any person whose election, or nomination for election by the
stockholders, is approved by a vote of at least two-thirds of the Original
Directors who are still in office shall be considered an Original Director for
all purposes (including approving the election or nomination of subsequent
directors).

                  (e) Approval by the stockholders of the Company of a complete
liquidation or dissolution of the Company.

         3. EMPLOYMENT PERIOD. The Company hereby agrees to continue the
Executive in its employ, subject to the terms and conditions of this Agreement,
for the period (the "Employment Period")commencing on the Change of Control Date
and ending on the third anniversary of such date, unless sooner terminated
pursuant to Section 5.

         4.       TERMS OF EMPLOYMENT.  (a)  Position and Duties.

                           (i) During the Employment Period, (A) the Executive's
position (including status, offices, titles and reporting requirements),
authority, duties and responsibilities shall be at least commensurate in all
material respects with the most significant of those held, exercised and
assigned to the Executive at any time during the 120-day period immediately
preceding the Change of Control Date and (B) the Executive's services shall be
performed within the Statesville/Charlotte, North Carolina, area, unless he
otherwise consents. Subject to the foregoing, the Executive may be

                                       2
<PAGE>

transferred to the payroll of an entity that is controlled by, or controls,
the Company, and in such event the term "Company" shall be deemed to include
such entity.

                           (ii) During the Employment Period, and excluding any
periods of vacation and sick leave to which the Executive is entitled, the
Executive agrees to devote his attention and time during normal business hours
to the business and affairs of the Company and, to the extent necessary to
discharge the responsibilities assigned to the Executive hereunder, to use the
Executive's reasonable best efforts to perform faithfully and efficiently such
responsibilities. It shall not be a violation of this Agreement for the
Executive to (A) serve on corporate, civic or charitable boards or committees,
(B) deliver lectures, fulfill speaking engagements or teach at educational
institutions and (C) manage personal investments, so long as such activities do
not significantly interfere with the performance of the Executive's
responsibilities as an employee of the Company in accordance with this
Agreement.

                  (b)      Compensation.

                           (i) Base Salary. During the Employment Period, the
Executive shall receive an annual base salary ("Annual Base Salary"), which
shall be paid at a monthly rate, at least equal to twelve times the highest
monthly base salary paid or payable, including any base salary which has been
earned but deferred, to the Executive by the Company in respect of the
twelve-month period immediately preceding the month in which the Change of
Control Date occurs. During the Employment Period, the Annual Base Salary shall
be reviewed no more than 12 months after the last salary increase awarded to the
Executive prior to the Change of Control Date and thereafter at least annually.
Any increase in Annual Base Salary shall not serve to limit or reduce any other
obligation to the Executive under this Agreement. Annual Base Salary shall not
be reduced after any such increase and the term Annual Base Salary as utilized
in this Agreement shall refer to Annual Base Salary as so increased.

                           (ii) Annual Bonus. In addition to Annual Base Salary,
the Executive shall be awarded, for each fiscal year ending during the
Employment Period, an annual bonus (the "Annual Bonus") in cash at least equal
to the average of the Executive's bonus under the Company's annual incentive
bonus plan or any comparable bonus under any predecessor or successor plan, for
the last three full fiscal years prior to the Change of Control Date (annualized
in the event that the Executive was not employed by the Company for the whole of
such fiscal year) (the "Average Annual Bonus"). Each such Annual Bonus shall be
paid no later than the end of the second month of the fiscal year next following
the fiscal year for which the Annual Bonus is awarded, unless the Executive
shall elect to defer the receipt of such Annual Bonus.

                           (iii) Incentive, Savings and Retirement Plans. During
the Employment Period, the Executive shall be entitled to participate in all
incentive, stock option, savings and retirement plans, practices, policies and
programs applicable generally to other peer executives of the Company but in no
event shall such plans, practices, policies and programs provide the Executive
with incentive opportunities,

                                       3
<PAGE>

savings opportunities and retirement benefit opportunities, in each case,
less favorable than the most favorable of those provided by the Company for
the Executive under such plans, practices, policies and programs as in effect
at any time during the 120-day period immediately preceding the Change of
Control Date, except that the foregoing shall not be construed to require the
Company to provide stock options if the Company does not maintain a stock
option plan following the Change of Control, and benefits may be reduced
under a tax qualified plan if substitute benefits are provided under a
nonqualified plan.

                           (iv) Welfare Benefit Plans. During the Employment
Period, the Executive and/or the Executive's family, as the case may be, shall
be eligible for participation in and shall receive all benefits under welfare
benefit plans, practices, policies and programs provided by the Company
(including, without limitation, medical, prescription, dental, disability,
salary continuance, employee life, group life, accidental death and travel
accident insurance plans and programs) to the extent applicable generally to
other peer executives of the Company but in no event shall such plans,
practices, policies and programs provide the Executive with benefits which are
less favorable, in the aggregate, than the most favorable of such plans,
practices, policies and programs in effect for the Executive at any time during
the 120-day period immediately preceding the Change of Control Date.

                           (v) Expenses. During the Employment Period, the
Executive shall be entitled to receive prompt reimbursement for all reasonable
expenses incurred by the Executive in accordance with the policies, practices
and procedures of the Company in effect for the Executive at any time during the
120-day period immediately preceding the Change of Control Date.

                           (vi) Fringe Benefits. During the Employment Period,
the Executive shall be entitled to fringe benefits, in accordance with the most
favorable plans, practices, programs and policies of the Company in effect for
the Executive at any time during the 120-day period immediately preceding the
Change of Control Date.

                           (vii) Office and Support Staff. During the Employment
Period, the Executive shall be entitled to an office or offices of a size and
with furnishings and other appointments, and to personal secretarial and other
assistance, at least equal to those provided to the Executive by the Company at
any time during the 120-day period immediately preceding the Change of Control
Date.

                           (viii) Vacation. During the Employment Period, the
Executive shall be entitled to paid vacations in accordance with the plans,
policies, programs and practices of the Company at least as favorable as those
in effect for the Executive at any time during the 120-day period immediately
preceding the Change of Control Date.

         5. TERMINATION OF EMPLOYMENT. (a) Disability. If the Company determines
in good faith that Disability of the Executive has occurred during the
Employment Period (pursuant to the definition of Disability set forth below), it
may give to the Executive written notice in accordance with Section 11(b) of
this Agreement of its intention to

                                       4
<PAGE>

terminate the Executive's employment. In such event, the Executive's
employment with the Company shall terminate effective on the 30th day after
receipt of such notice by the Executive (the "Disability Effective Date"),
provided that, within the 30 days after such receipt, the Executive shall not
have returned to full-time performance of the Executive's duties. For
purposes of this Agreement, "Disability" shall mean the absence of the
Executive from the Executive's duties with the Company on a full-time basis
for 180 consecutive days as a result of incapacity due to mental or physical
illness which is determined to be total and permanent by a physician selected
by the Company or its insurers and reasonably acceptable to the Executive or
the Executive's legal representative.

                  (b) Cause. The Company may terminate the Executive's
employment during the Employment Period for Cause. For purposes of this
Agreement, "Cause" shall mean:

                           (i) the willful and continued failure of the
Executive to perform substantially the Executive's duties with the Company or
one of its affiliates (other than any such failure resulting from incapacity due
to physical or mental illness), after a written demand for substantial
performance is delivered to the Executive by the Board or the Chief Executive
Officer of the Company which specifically identifies the manner in which the
Board or Chief Executive Officer believes that the Executive has not
substantially performed the Executive's duties, or

                           (ii) the willful engaging by the Executive in illegal
conduct or gross misconduct which is materially and demonstrably injurious to
the Company.

For purposes of this provision, no act or failure to act on the part of the
Executive, shall be considered "willful" unless it is done, or omitted to be
done, by the Executive in bad faith or without reasonable belief that the
Executive's action or omission was in the best interests of the Company. Any
act, or failure to act, based upon authority given pursuant to a resolution duly
adopted by the Board or upon the instructions of the Chief Executive Officer or
a senior officer of the Company or based upon the advice of counsel for the
Company shall be conclusively presumed to be done, or omitted to be done, by the
Executive in good faith and in the best interests of the Company. The cessation
of employment of the Executive shall not be deemed to be for Cause unless and
until there shall have been delivered to the Executive a copy of a resolution
duly adopted by the Board (or the Executive Committee of the Board) at a meeting
of the Board (or Executive Committee) called and held for such purpose (after
reasonable notice is provided to the Executive and the Executive is given an
opportunity, together with counsel, to be heard before the Board (or Executive
Committee)), finding that, in the good faith opinion of the Board (or Executive
Committee), the Executive is guilty of the conduct described in subparagraph (i)
or (ii) above, and specifying the particulars thereof in detail.

                  (c) Good Reason. The Executive's employment may be terminated
by the Executive for Good Reason. For purposes of this Agreement, "Good Reason"
shall mean:

                                       5
<PAGE>

                           (i) the assignment to the Executive of any duties
inconsistent in any material respect with the Executive's position (including
status, offices, titles and reporting requirements), authority, duties or
responsibilities as contemplated by Section 4(a) of this Agreement, or any other
action by the Company which results in a diminution in such position, authority,
duties or responsibilities, excluding for this purpose an isolated and
insubstantial action not taken in bad faith and which is remedied by the Company
promptly after receipt of notice thereof given by the Executive;

                           (ii) any failure by the Company to comply with any of
the provisions of Section 4(b) of this Agreement, other than failure not
occurring in bad faith and which is remedied by the Company promptly after
receipt of notice thereof given by the Executive;

                           (iii) the Company's requiring the Executive to be
based at any office or location other than as provided in Section 4(a)(i)(B)
hereof or the Company's requiring the Executive without his consent to travel on
Company business to a substantially greater extent than required immediately
prior to the Change of Control Date;

                           (iv) any purported termination by the Company of the
Executive's employment otherwise than as expressly permitted by this Agreement;
or

                           (v) any failure by the Company to comply with and
satisfy Section 10(c) of this Agreement.

For purposes of this Section 5(c), any good faith determination of "Good Reason"
made by the Executive shall be conclusive.

                  (d) Notice of Termination. Any termination by the Company for
cause, or by the Executive for Good Reason, shall be communicated by Notice of
Termination to the other party hereto given in accordance with Section 11(b) of
this Agreement. For purposes of this Agreement, a "Notice of Termination" means
a written notice which (i) indicates the specific termination provision in this
Agreement relied upon, (ii) to the extent applicable, sets forth in reasonable
detail the facts and circumstances claimed to provide a basis for termination of
the Executive's employment under the provision so indicated and (iii) if the
Date of Termination (as defined below) is other than the date of receipt of such
notice, specifies the termination date (which date shall be not more than thirty
days after the giving of such notice). The failure by the Executive or the
Company to set forth in the Notice of Termination any fact or circumstance which
contributes to a showing of Good Reason or Cause shall not waive any right of
the Executive or the Company, respectively, hereunder or preclude the Executive
or the Company, respectively, from asserting such fact or circumstance in
enforcing the Executive's or the Company's rights hereunder.

                  (e) Date of Termination. "Date of Termination" means (i) if
the Executive's employment is terminated by the Company for Cause, or by the
Executive

                                       6
<PAGE>

for Good Reason, the date of receipt of the Notice of Termination or any
later date specified therein, as the case may be, (ii) if the Executive's
employment is terminated by the Company other than for Cause or Disability,
the date on which the Company notifies the Executive of such termination and
(iii) if the Executive's employment is terminated by reason of death or
Disability, the date of death of the Executive or the Disability Effective
Date, as the case may be. The Employment Period shall end on the Date of
Termination.

         6. OBLIGATIONS OF THE COMPANY UPON TERMINATION. (a) Termination by
Company Not for Cause; Resignation by Executive for Good Reason. If, during the
Employment Period, the Company shall terminate the Executive's employment other
than for Cause or Disability or the Executive shall terminate employment for
Good Reason, then, in addition to all compensation that has been earned but not
yet paid on the Date of Termination, the Executive shall be entitled to the
following. The amounts to be paid to the Executive pursuant to subparagraphs (i)
through (iv), as applicable, shall be paid in a lump sum in cash within 30 days
after the Date of Termination. All references in subparagraphs (ii) through (iv)
to specific employee benefit plans shall be appropriately adjusted to refer to
any amendments or successors to such plans as in effect on the Date of
Termination, subject to Section 4(b).

                           (i) The Company shall pay to the Executive an amount
equal to either:

                                 A. if the Date of Termination occurs on or
         before the first anniversary of the Change of Control Date, the sum of
         the Executive's Annual Base Salary plus his Average Annual Bonus; or

                                 B. if the Date of Termination occurs after the
         first anniversary of the Change of Control Date, one-half the sum of
         the Executive's Annual Base Salary plus his Average Annual Bonus.

                           (ii) If the Executive is a participant in the
Kewaunee Scientific Corporation Pension Equalization Plan (the "Equalization
Plan"), his benefit under the Equalization Plan shall be paid in a single lump
sum computed as provided in Section 3.2 of the Equalization Plan regardless of
whether it exceeds $20,000, and shall be increased by an amount equal to the
additional benefit the Executive would have accrued under both the Equalization
Plan and the Re-Established Retirement Plan for Salaried Employees of Kewaunee
Scientific Corporation (the "Retirement Plan") if the Executive's employment had
continued until the end of the Protection Period as defined below, based on the
assumption that the Executive's compensation throughout the Protection Period
would have been that required by Section 4(b)(i) and Section 4(b)(ii). The
provisions of this Section 6(a)(ii) shall be considered an amendment to the
Equalization Plan consented to by the Executive. For purposes of this Agreement,
the "Protection Period" shall mean a period that begins on the Date of
Termination and ends on the first anniversary of the Date of Termination if the
Date of Termination occurs on or before the first anniversary of the Change of
Control Date, or the date that

                                       7


<PAGE>


is six months after the Date of Termination if the Date of Termination occurs
after the first anniversary of the Change of Control Date.

                           (iii) If the Executive is a participant in the
Kewaunee Scientific Corporation Executive Deferred Compensation Plan (the
"Deferred Compensation Plan"), his benefit under the Deferred Compensation Plan
shall be paid in a single lump sum pursuant to Section 5.2 of the Deferred
Compensation Plan regardless of whether he had elected a different form of
benefit, and shall be increased by an amount equal to the additional employer
matching contributions the Executive would have received under both the Deferred
Compensation Plan and the 401K Incentive Savings Plan for Salaried and Hourly
Employees of Kewaunee Scientific Corporation as if the Executive's employment
had continued until the end of the Protection Period, based on the assumption
that the Executive's compensation throughout the Protection Period would have
been that required by Section 4(b)(i) and Section 4(b)(ii), and that the
Executive's would have elected to defer his compensation under both such plans
at the same rate that he had elected immediately prior to the Termination Date.
The provisions of this Section 6(a)(iii) shall be considered an amendment to the
Deferred Compensation Plan consented to by the Executive.

                           (iv) If the Executive is a participant in the
Kewaunee Scientific Corporation Special Employee Benefit Plan (the "SEBP"), he
shall also receive a payment equal to the present value of the vested death
benefit, if any, to which the Executive's beneficiaries would have been entitled
under the SEBP if the Executive's employment had continued until the end of the
Protection Period, based on the assumption that the Executive's compensation
throughout the Protection Period would have been that required by Section
4(b)(i) and Section 4(b)(ii). Such present value shall be determined as if the
death benefit were payable at the end of the Executive's life expectancy,
determined as of the date of payment, and discounted to the date of payment,
using the same mortality and interest rate assumptions used to calculate lump
sum benefits under the Retirement Plan. The provisions of this Section 6(a)(iv)
shall be considered an amendment to the SEBP consented to by the Executive, and
the amount of such payment shall be in full satisfaction of all amounts owed to
the Executive's beneficiaries under the SEBP.

                           (v) During the Protection Period, or such longer
period as may be provided by the terms of the appropriate plan, program,
practice or policy, the Company shall continue benefits to the Executive and/or
the Executive's family at least equal to those which would have been provided to
them in accordance with the plans, programs, practices and policies described in
Section 4(b)(iv) of this Agreement as if the Executive's employment had not been
terminated or, if more favorable to the Executive, as in effect generally at any
time thereafter with respect to other peer executives of the Company and their
families, provided, however, that if the Executive becomes reemployed with
another employer and is eligible to receive medical or other welfare benefits
under another employer-provided plan, the medical and other welfare benefits
described herein shall be secondary to those provided under such other plan
during such applicable period of eligibility, and for purposes of determining
eligibility (but not the time of commencement of benefits) of the Executive for
retiree benefits pursuant to


                                       8


<PAGE>


such plans, practices, programs and policies, the Executive shall be
considered to have remained employed until the end of the Protection Period
and to have retired on the last day of the Protection Period.

                  (b) Death. If the Executive dies during the Employment Period,
this Agreement shall terminate without further obligation to the Executive or
his estate other than the obligation to pay any compensation or benefits that
have been earned but not paid on the Date of Termination, and any
post-termination, life insurance or death benefits that are provided under the
Company's normal benefit plans and policies; provided that the death benefits
payable to the Employee's beneficiaries or estate shall be at least equal to the
most favorable benefits provided by the Company to the estates and beneficiaries
of peer executives of the Company (taking into account differences in
compensation) under such plans, programs, practices and policies relating to
death benefits, if any, as in effect with respect to other peer executives and
their beneficiaries at any time during the 120-day period immediately preceding
the Change of Control Date.

                  (c) Disability. If the Executive's employment shall be
terminated during the Employment Period by reason of the Executive's Disability,
this Agreement shall terminate without further obligation to the Executive other
than the obligation to pay any compensation or benefits that have been earned
but not paid on the Date of Termination, and any post-termination benefits or
disability benefits that are provided under the Company's normal benefit plans
and policies; provided that the disability benefits payable to the Executive
shall be at least equal to the most favorable of those generally provided by the
Company to disabled executives and/or their families in accordance with such
plans, programs, practices and policies relating to disability, if any, as in
effect generally with respect to other peer executives and their families at any
time during the 120-day period immediately preceding the Change of Control Date.

                  (d) Cause; Other than for Good Reason. If the Executive's
employment shall be terminated for Cause during the Employment Period, or if the
Executive shall resign during the Employment Period other than for Good Reason
this Agreement shall terminate without further obligation to the Executive other
than the obligation to pay any compensation or benefits that have been earned
but not paid on the Date of Termination, and any post-termination benefits that
are provided under the Company's normal benefit plans and policies.

         7. NON-EXCLUSIVITY OF RIGHTS. Nothing in this Agreement shall prevent
or limit the Executive's continuing or future participation in any plan,
program, policy or practice (other than any severance pay plan) provided by the
Company and for which the Executive may qualify, nor, subject to Section 11(f),
shall anything herein limit or otherwise affect such rights as the Executive may
have under any contract or agreement with the Company. Amounts which are vested
benefits or which the Executive is otherwise entitled to receive under any plan,
policy, practice or program of or any contract or agreement with the Company at
or subsequent to the Date of Termination shall be payable in accordance with
such plan, policy, practice or program or contract or agreement except as
explicitly modified by this Agreement.

                                       9
<PAGE>

         8. FULL SETTLEMENT; LEGAL FEES. The Company's obligation to make the
payments provided for in this Agreement and otherwise to perform its obligations
hereunder shall not be affected by any set-off, counterclaim, recoupment,
defense or other claim, right or action which the Company may have against the
Executive or others. In no event shall the Executive be obligated to seek other
employment or take any other action by way of mitigation of the amounts payable
to the Executive under any of the provisions of this Agreement and except as
specifically provided in Section 6(a)(iii), such amounts shall not be reduced
whether or not the Executive obtains other employment. The Company agrees to pay
as incurred, to the full extent permitted by law, all legal fees and expense
which the Executive may reasonably incur as a result of any contest by the
Company, the Executive or others of the validity or enforceability of, or
liability under, any provision of this Agreement or any guarantee of performance
thereof (whether such contest is between the Company and the Executive or
between either of them and any third party, and including as a result of any
contest by the Executive about the amount of any payment pursuant to this
Agreement), plus in each case interest on any delayed payment at the applicable
Federal rate provided for in Section 7872(f) (2) (A) of the Internal Revenue
Code of 1986, as amended (the "Code"); provided, however, that if the contest is
between the Executive and the Company, the Company shall be obligated to pay the
Executive's legal fees and expenses if the Executive prevails to any extent in
such contest.

         9. CONFIDENTIAL INFORMATION. The Executive shall hold in a fiduciary
capacity for the benefit of the Company all secret or confidential information,
knowledge or data relating to the Company, and their respective businesses,
which shall have been obtained by the Executive during the Executive's
employment by the Company and which shall not be or become public knowledge
(other than by acts by the Executive or representatives of the Executive in
violation of this Agreement). After termination of the Executive's employment
with the Company, the Executive shall not, without the prior written consent of
the Company or as may otherwise be required by law or legal process, communicate
or divulge any such information, knowledge or data to anyone other than the
Company and those designated by it. In no event shall an asserted violation of
the provisions of this Section 9 constitute a basis for deferring or withholding
any amounts otherwise payable to the Executive under this Agreement.

         10. SUCCESSORS. (a) This Agreement is personal to the Executive and
without the prior written consent of the Company shall not be assignable by the
Executive otherwise than by will or the laws of descent and distribution. This
Agreement shall inure to the benefit of and be enforceable by the Executive's
legal representatives.

                  (b) This Agreement shall inure to the benefit of and be
binding upon the Company and its successors and assigns.

                  (c) The Company will require any successor (whether direct or
indirect, by purchase, merger, consolidation or otherwise) to all or
substantially all of the business and/or assets of the Company to assume
expressly and agree to perform this Agreement in the same manner and to the same
extent that the Company would be required to perform it if no such succession
had taken place. As used in this

                                       10
<PAGE>

Agreement, "Company" shall mean the Company as hereinbefore defined and any
successor to its business and/or assets as aforesaid which assumes and agrees
to perform this Agreement by operation of law, or otherwise.

         11. MISCELLANEOUS. (a) This Agreement shall be governed by and
construed in accordance with the laws of the State of North Carolina without
reference to principles of conflict of laws. The captions of this Agreement are
not part of the provisions hereof and shall have no force or effect. This
Agreement may not be amended or modified otherwise than by a written agreement
executed by the parties hereto or their respective successors and legal
representatives.

                  (b) All notices and other communications hereunder shall be in
writing and shall be given by hand delivery to the other party or by registered
or certified mail, return receipt requested, postage prepaid, addressed as
follows:

                  If to the Executive:    James J. Rossi
                                          19607 Galleon View Drive
                                          Cornelius, NC 28031

                  If to the Company:      Kewaunee Scientific Corporation
                                          2700 West Front Street
                                          Statesville, NC 28677
                                          Attention:  Chief Executive Officer

or to such other address as either party shall have furnished to the other in
writing in accordance herewith. Notice and communications shall be effective
when actually received by the addressee.

                  (c) The invalidity or unenforceability of any provision of
this Agreement shall not affect the validity or enforceability of any other
provision of this Agreement.

                  (d) The Company may withhold from any amounts payable under
this Agreement such Federal, state, local or foreign taxes as shall be required
to be withheld pursuant to any applicable law or regulation.

                  (e) The Executive's or the Company's failure to insist upon
strict compliance with any provision hereof or any other provision of this
Agreement or the failure to assert any right the Executive or the Company may
have hereunder, including, without limitation, the right of the Executive to
terminate employment for Good Reason pursuant to Section 5(c) (i)-(v) of this
Agreement, shall not be deemed to be a waiver of such provision or right or any
other provision or right of this Agreement.

                  (f) The Executive and the Company acknowledge that, except as
may otherwise be provided under any other written agreement between the
Executive and the Company, the employment of the Executive by the Company is "at
will" and, prior to the Change of Control Date, the Executive's employment may
be terminated by either the Executive or the Company at any time prior to the
Change of Control Date, in which case the Executive shall have no further rights
under this Agreement. From and after

                                       11
<PAGE>

the Change of Control Date this Agreement shall supersede any other agreement
between the parties with respect to the subject matter hereof.

         IN WITNESS WHEREOF, the Executive has hereunto set the Executive's hand
and, pursuant to the authorization from its Board of Directors, the Company has
caused this Agreement to be executed in its name on its behalf, all as of the
day and year first above written.

                                          /s/ James J. Rossi
                                          ---------------------------
                                                (Executive)

                                          KEWAUNEE SCIENTIFIC CORPORATION

                                          By:  /s/ Eli Manchester, Jr.
                                             ------------------------
                                          Its: Chairman and CEO
                                             ------------------------

                                       12

<PAGE>

                                CHANGE OF CONTROL
                              EMPLOYMENT AGREEMENT

         AGREEMENT by and between Kewaunee Scientific Corporation, a Delaware
corporation (the "Company") and Kurt P. Rindoks (the "Executive"), dated as of
the 20th day of January, 2000.

         The Board of Directors of the Company (the "Board") has determined that
it is in the best interests of the Company and its stockholders to assure that
the Company will have the continued dedication of the Executive, notwithstanding
the possibility, threat or occurrence of a Change of Control (as defined below)
of the Company. The Board believes it is imperative to diminish the distraction
of the Executive by virtue of the personal uncertainties and risks created by a
pending or threatened Change of Control and to encourage the Executive's full
attention and dedication to the Company currently and in the event of any
threatened or pending Change of Control, and to provide the Executive with
compensation and benefits arrangements upon a Change of Control which ensure
that the compensation and benefits expectations of the Executive will be
satisfied and which are competitive with those of other corporations. Therefore,
in order to accomplish these objectives the Board has caused the Company to
enter into this Agreement.

NOW, THEREFORE, IT IS HEREBY AGREED AS FOLLOWS:

         1. CHANGE OF CONTROL DATE. (a) The "Change of Control Date" shall mean
the first date during the term of this Agreement on which a Change of Control
(as defined in Section 2) occurs. Anything in this Agreement to the contrary
notwithstanding, if a Change of Control occurs and if the Executive's employment
with the Company is terminated prior to the date on which the Change of Control
occurs, and if it is reasonably demonstrated by the Executive that such
termination of employment (i) was at the request of a third party who has taken
steps reasonably calculated to effect a Change of Control or (ii) otherwise
arose in connection with or in anticipation of a Change of Control, then for all
purposes of this Agreement the "Change of Control Date" shall mean the date
immediately prior to the date of such termination of employment.

                  (b) The term of this Agreement shall commence on the date
hereof and, if no Change of Control Date occurs, shall end on the third
anniversary of the date hereof; subject to extension by mutual agreement of the
parties. If a Change of Control Date occurs on or before the third anniversary
of the date hereof, the term of this Agreement shall end on the later of the
last day of the Employment Period as defined in Section 3 (whether such date is
prior to or after such third anniversary) or the end of the Protection Period as
defined in Section 6.

         2. CHANGE OF CONTROL. For the purpose of this Agreement, a "Change of
Control" shall mean:

<PAGE>

                  (a) The consummation of a transaction in which the Company is
merged, consolidated or reorganized into or with another corporation or other
legal entity, if as a result of such transaction less than 50% of the
outstanding voting securities or other capital interests of the surviving,
resulting or acquiring entity are owned in the aggregate, directly or
indirectly, by the stockholders of the Company immediately prior to such
transaction; or

                  (b) The sale or exchange of more than 50% of the outstanding
shares of common stock of the Company pursuant to an offer made generally for
the acquisition of the common stock of the Company, unless as a result of such
exchange at least 50% of the outstanding voting securities or other capital
interests of the acquiring entity are owned in the aggregate, directly or
indirectly, by the stockholders of the Company immediately prior to such
transaction; or

                  (c) The sale by the Company of all or substantially all of its
business and/or assets to any other corporation or other legal entity, if less
than 50% of the outstanding voting securities or other capital interests of the
acquiring entity are owned in the aggregate, directly or indirectly, by the
persons who were stockholders of the Company immediately before or after such
date; or

                  (d) A change in the membership of the Board such that the
persons who were members of the Board on the date of this Agreement (the
"Original Directors") cease to constitute at least a majority of the Board. For
this purpose, any person whose election, or nomination for election by the
stockholders, is approved by a vote of at least two-thirds of the Original
Directors who are still in office shall be considered an Original Director for
all purposes (including approving the election or nomination of subsequent
directors).

                  (e) Approval by the stockholders of the Company of a complete
liquidation or dissolution of the Company.

         3. EMPLOYMENT PERIOD. The Company hereby agrees to continue the
Executive in its employ, subject to the terms and conditions of this Agreement,
for the period (the "Employment Period")commencing on the Change of Control Date
and ending on the third anniversary of such date, unless sooner terminated
pursuant to Section 5.

         4.       TERMS OF EMPLOYMENT.  (a)  Position and Duties.

                           (i) During the Employment Period, (A) the Executive's
position (including status, offices, titles and reporting requirements),
authority, duties and responsibilities shall be at least commensurate in all
material respects with the most significant of those held, exercised and
assigned to the Executive at any time during the 120-day period immediately
preceding the Change of Control Date and (B) the Executive's services shall be
performed within the Statesville/Charlotte, North Carolina, area, unless he
otherwise consents. Subject to the foregoing, the Executive may be

                                       2
<PAGE>

transferred to the payroll of an entity that is controlled by, or controls,
the Company, and in such event the term "Company" shall be deemed to include
such entity.

                           (ii) During the Employment Period, and excluding any
periods of vacation and sick leave to which the Executive is entitled, the
Executive agrees to devote his attention and time during normal business hours
to the business and affairs of the Company and, to the extent necessary to
discharge the responsibilities assigned to the Executive hereunder, to use the
Executive's reasonable best efforts to perform faithfully and efficiently such
responsibilities. It shall not be a violation of this Agreement for the
Executive to (A) serve on corporate, civic or charitable boards or committees,
(B) deliver lectures, fulfill speaking engagements or teach at educational
institutions and (C) manage personal investments, so long as such activities do
not significantly interfere with the performance of the Executive's
responsibilities as an employee of the Company in accordance with this
Agreement.

                  (b)      Compensation.

                           (i) Base Salary. During the Employment Period, the
Executive shall receive an annual base salary ("Annual Base Salary"), which
shall be paid at a monthly rate, at least equal to twelve times the highest
monthly base salary paid or payable, including any base salary which has been
earned but deferred, to the Executive by the Company in respect of the
twelve-month period immediately preceding the month in which the Change of
Control Date occurs. During the Employment Period, the Annual Base Salary shall
be reviewed no more than 12 months after the last salary increase awarded to the
Executive prior to the Change of Control Date and thereafter at least annually.
Any increase in Annual Base Salary shall not serve to limit or reduce any other
obligation to the Executive under this Agreement. Annual Base Salary shall not
be reduced after any such increase and the term Annual Base Salary as utilized
in this Agreement shall refer to Annual Base Salary as so increased.

                           (ii) Annual Bonus. In addition to Annual Base Salary,
the Executive shall be awarded, for each fiscal year ending during the
Employment Period, an annual bonus (the "Annual Bonus") in cash at least equal
to the average of the Executive's bonus under the Company's annual incentive
bonus plan or any comparable bonus under any predecessor or successor plan, for
the last three full fiscal years prior to the Change of Control Date (annualized
in the event that the Executive was not employed by the Company for the whole of
such fiscal year) (the "Average Annual Bonus"). Each such Annual Bonus shall be
paid no later than the end of the second month of the fiscal year next following
the fiscal year for which the Annual Bonus is awarded, unless the Executive
shall elect to defer the receipt of such Annual Bonus.

                           (iii) Incentive, Savings and Retirement Plans. During
the Employment Period, the Executive shall be entitled to participate in all
incentive, stock option, savings and retirement plans, practices, policies and
programs applicable generally to other peer executives of the Company but in no
event shall such plans, practices, policies and programs provide the Executive
with incentive opportunities,

                                       3
<PAGE>

savings opportunities and retirement benefit opportunities, in each case,
less favorable than the most favorable of those provided by the Company for
the Executive under such plans, practices, policies and programs as in effect
at any time during the 120-day period immediately preceding the Change of
Control Date, except that the foregoing shall not be construed to require the
Company to provide stock options if the Company does not maintain a stock
option plan following the Change of Control, and benefits may be reduced
under a tax qualified plan if substitute benefits are provided under a
nonqualified plan.

                           (iv) Welfare Benefit Plans. During the Employment
Period, the Executive and/or the Executive's family, as the case may be, shall
be eligible for participation in and shall receive all benefits under welfare
benefit plans, practices, policies and programs provided by the Company
(including, without limitation, medical, prescription, dental, disability,
salary continuance, employee life, group life, accidental death and travel
accident insurance plans and programs) to the extent applicable generally to
other peer executives of the Company but in no event shall such plans,
practices, policies and programs provide the Executive with benefits which are
less favorable, in the aggregate, than the most favorable of such plans,
practices, policies and programs in effect for the Executive at any time during
the 120-day period immediately preceding the Change of Control Date.

                           (v) Expenses. During the Employment Period, the
Executive shall be entitled to receive prompt reimbursement for all reasonable
expenses incurred by the Executive in accordance with the policies, practices
and procedures of the Company in effect for the Executive at any time during the
120-day period immediately preceding the Change of Control Date.

                           (vi) Fringe Benefits. During the Employment Period,
the Executive shall be entitled to fringe benefits, in accordance with the most
favorable plans, practices, programs and policies of the Company in effect for
the Executive at any time during the 120-day period immediately preceding the
Change of Control Date.

                           (vii) Office and Support Staff. During the Employment
Period, the Executive shall be entitled to an office or offices of a size and
with furnishings and other appointments, and to personal secretarial and other
assistance, at least equal to those provided to the Executive by the Company at
any time during the 120-day period immediately preceding the Change of Control
Date.

                           (viii) Vacation. During the Employment Period, the
Executive shall be entitled to paid vacations in accordance with the plans,
policies, programs and practices of the Company at least as favorable as those
in effect for the Executive at any time during the 120-day period immediately
preceding the Change of Control Date.

         5. TERMINATION OF EMPLOYMENT. (a) Disability. If the Company determines
in good faith that Disability of the Executive has occurred during the
Employment Period (pursuant to the definition of Disability set forth below), it
may give to the Executive written notice in accordance with Section 11(b) of
this Agreement of its intention to

                                       4
<PAGE>

terminate the Executive's employment. In such event, the Executive's
employment with the Company shall terminate effective on the 30th day after
receipt of such notice by the Executive (the "Disability Effective Date"),
provided that, within the 30 days after such receipt, the Executive shall not
have returned to full-time performance of the Executive's duties. For
purposes of this Agreement, "Disability" shall mean the absence of the
Executive from the Executive's duties with the Company on a full-time basis
for 180 consecutive days as a result of incapacity due to mental or physical
illness which is determined to be total and permanent by a physician selected
by the Company or its insurers and reasonably acceptable to the Executive or
the Executive's legal representative.

                  (b) Cause. The Company may terminate the Executive's
employment during the Employment Period for Cause. For purposes of this
Agreement, "Cause" shall mean:

                           (i) the willful and continued failure of the
Executive to perform substantially the Executive's duties with the Company or
one of its affiliates (other than any such failure resulting from incapacity due
to physical or mental illness), after a written demand for substantial
performance is delivered to the Executive by the Board or the Chief Executive
Officer of the Company which specifically identifies the manner in which the
Board or Chief Executive Officer believes that the Executive has not
substantially performed the Executive's duties, or

                           (ii) the willful engaging by the Executive in illegal
conduct or gross misconduct which is materially and demonstrably injurious to
the Company.

For purposes of this provision, no act or failure to act on the part of the
Executive, shall be considered "willful" unless it is done, or omitted to be
done, by the Executive in bad faith or without reasonable belief that the
Executive's action or omission was in the best interests of the Company. Any
act, or failure to act, based upon authority given pursuant to a resolution duly
adopted by the Board or upon the instructions of the Chief Executive Officer or
a senior officer of the Company or based upon the advice of counsel for the
Company shall be conclusively presumed to be done, or omitted to be done, by the
Executive in good faith and in the best interests of the Company. The cessation
of employment of the Executive shall not be deemed to be for Cause unless and
until there shall have been delivered to the Executive a copy of a resolution
duly adopted by the Board (or the Executive Committee of the Board) at a meeting
of the Board (or Executive Committee) called and held for such purpose (after
reasonable notice is provided to the Executive and the Executive is given an
opportunity, together with counsel, to be heard before the Board (or Executive
Committee)), finding that, in the good faith opinion of the Board (or Executive
Committee), the Executive is guilty of the conduct described in subparagraph (i)
or (ii) above, and specifying the particulars thereof in detail.

                  (c) Good Reason. The Executive's employment may be terminated
by the Executive for Good Reason. For purposes of this Agreement, "Good Reason"
shall mean:

                                       5
<PAGE>

                           (i) the assignment to the Executive of any duties
inconsistent in any material respect with the Executive's position (including
status, offices, titles and reporting requirements), authority, duties or
responsibilities as contemplated by Section 4(a) of this Agreement, or any other
action by the Company which results in a diminution in such position, authority,
duties or responsibilities, excluding for this purpose an isolated and
insubstantial action not taken in bad faith and which is remedied by the Company
promptly after receipt of notice thereof given by the Executive;

                           (ii) any failure by the Company to comply with any of
the provisions of Section 4(b) of this Agreement, other than failure not
occurring in bad faith and which is remedied by the Company promptly after
receipt of notice thereof given by the Executive;

                           (iii) the Company's requiring the Executive to be
based at any office or location other than as provided in Section 4(a)(i)(B)
hereof or the Company's requiring the Executive without his consent to travel on
Company business to a substantially greater extent than required immediately
prior to the Change of Control Date;

                           (iv) any purported termination by the Company of the
Executive's employment otherwise than as expressly permitted by this Agreement;
or

                           (v) any failure by the Company to comply with and
satisfy Section 10(c) of this Agreement.

For purposes of this Section 5(c), any good faith determination of "Good Reason"
made by the Executive shall be conclusive.

                  (d) Notice of Termination. Any termination by the Company for
cause, or by the Executive for Good Reason, shall be communicated by Notice of
Termination to the other party hereto given in accordance with Section 11(b) of
this Agreement. For purposes of this Agreement, a "Notice of Termination" means
a written notice which (i) indicates the specific termination provision in this
Agreement relied upon, (ii) to the extent applicable, sets forth in reasonable
detail the facts and circumstances claimed to provide a basis for termination of
the Executive's employment under the provision so indicated and (iii) if the
Date of Termination (as defined below) is other than the date of receipt of such
notice, specifies the termination date (which date shall be not more than thirty
days after the giving of such notice). The failure by the Executive or the
Company to set forth in the Notice of Termination any fact or circumstance which
contributes to a showing of Good Reason or Cause shall not waive any right of
the Executive or the Company, respectively, hereunder or preclude the Executive
or the Company, respectively, from asserting such fact or circumstance in
enforcing the Executive's or the Company's rights hereunder.

                  (e) Date of Termination. "Date of Termination" means (i) if
the Executive's employment is terminated by the Company for Cause, or by the
Executive

                                       6
<PAGE>

for Good Reason, the date of receipt of the Notice of Termination or any
later date specified therein, as the case may be, (ii) if the Executive's
employment is terminated by the Company other than for Cause or Disability,
the date on which the Company notifies the Executive of such termination and
(iii) if the Executive's employment is terminated by reason of death or
Disability, the date of death of the Executive or the Disability Effective
Date, as the case may be. The Employment Period shall end on the Date of
Termination.

         6. OBLIGATIONS OF THE COMPANY UPON TERMINATION. (a) Termination by
Company Not for Cause; Resignation by Executive for Good Reason. If, during the
Employment Period, the Company shall terminate the Executive's employment other
than for Cause or Disability or the Executive shall terminate employment for
Good Reason, then, in addition to all compensation that has been earned but not
yet paid on the Date of Termination, the Executive shall be entitled to the
following. The amounts to be paid to the Executive pursuant to subparagraphs (i)
through (iv), as applicable, shall be paid in a lump sum in cash within 30 days
after the Date of Termination. All references in subparagraphs (ii) through (iv)
to specific employee benefit plans shall be appropriately adjusted to refer to
any amendments or successors to such plans as in effect on the Date of
Termination, subject to Section 4(b).

                           (i) The Company shall pay to the Executive an amount
equal to either:

                                 A. if the Date of Termination occurs on or
         before the first anniversary of the Change of Control Date, the sum of
         the Executive's Annual Base Salary plus his Average Annual Bonus; or

                                 B. if the Date of Termination occurs after the
         first anniversary of the Change of Control Date, one-half the sum of
         the Executive's Annual Base Salary plus his Average Annual Bonus.

                           (ii) If the Executive is a participant in the
Kewaunee Scientific Corporation Pension Equalization Plan (the "Equalization
Plan"), his benefit under the Equalization Plan shall be paid in a single lump
sum computed as provided in Section 3.2 of the Equalization Plan regardless of
whether it exceeds $20,000, and shall be increased by an amount equal to the
additional benefit the Executive would have accrued under both the Equalization
Plan and the Re-Established Retirement Plan for Salaried Employees of Kewaunee
Scientific Corporation (the "Retirement Plan") if the Executive's employment had
continued until the end of the Protection Period as defined below, based on the
assumption that the Executive's compensation throughout the Protection Period
would have been that required by Section 4(b)(i) and Section 4(b)(ii). The
provisions of this Section 6(a)(ii) shall be considered an amendment to the
Equalization Plan consented to by the Executive. For purposes of this Agreement,
the "Protection Period" shall mean a period that begins on the Date of
Termination and ends on the first anniversary of the Date of Termination if the
Date of Termination occurs on or before the first anniversary of the Change of
Control Date, or the date that

                                       7


<PAGE>


is six months after the Date of Termination if the Date of Termination occurs
after the first anniversary of the Change of Control Date.

                           (iii) If the Executive is a participant in the
Kewaunee Scientific Corporation Executive Deferred Compensation Plan (the
"Deferred Compensation Plan"), his benefit under the Deferred Compensation Plan
shall be paid in a single lump sum pursuant to Section 5.2 of the Deferred
Compensation Plan regardless of whether he had elected a different form of
benefit, and shall be increased by an amount equal to the additional employer
matching contributions the Executive would have received under both the Deferred
Compensation Plan and the 401K Incentive Savings Plan for Salaried and Hourly
Employees of Kewaunee Scientific Corporation as if the Executive's employment
had continued until the end of the Protection Period, based on the assumption
that the Executive's compensation throughout the Protection Period would have
been that required by Section 4(b)(i) and Section 4(b)(ii), and that the
Executive's would have elected to defer his compensation under both such plans
at the same rate that he had elected immediately prior to the Termination Date.
The provisions of this Section 6(a)(iii) shall be considered an amendment to the
Deferred Compensation Plan consented to by the Executive.

                           (iv) If the Executive is a participant in the
Kewaunee Scientific Corporation Special Employee Benefit Plan (the "SEBP"), he
shall also receive a payment equal to the present value of the vested death
benefit, if any, to which the Executive's beneficiaries would have been entitled
under the SEBP if the Executive's employment had continued until the end of the
Protection Period, based on the assumption that the Executive's compensation
throughout the Protection Period would have been that required by Section
4(b)(i) and Section 4(b)(ii). Such present value shall be determined as if the
death benefit were payable at the end of the Executive's life expectancy,
determined as of the date of payment, and discounted to the date of payment,
using the same mortality and interest rate assumptions used to calculate lump
sum benefits under the Retirement Plan. The provisions of this Section 6(a)(iv)
shall be considered an amendment to the SEBP consented to by the Executive, and
the amount of such payment shall be in full satisfaction of all amounts owed to
the Executive's beneficiaries under the SEBP.

                           (v) During the Protection Period, or such longer
period as may be provided by the terms of the appropriate plan, program,
practice or policy, the Company shall continue benefits to the Executive and/or
the Executive's family at least equal to those which would have been provided to
them in accordance with the plans, programs, practices and policies described in
Section 4(b)(iv) of this Agreement as if the Executive's employment had not been
terminated or, if more favorable to the Executive, as in effect generally at any
time thereafter with respect to other peer executives of the Company and their
families, provided, however, that if the Executive becomes reemployed with
another employer and is eligible to receive medical or other welfare benefits
under another employer-provided plan, the medical and other welfare benefits
described herein shall be secondary to those provided under such other plan
during such applicable period of eligibility, and for purposes of determining
eligibility (but not the time of commencement of benefits) of the Executive for
retiree benefits pursuant to


                                       8


<PAGE>


such plans, practices, programs and policies, the Executive shall be
considered to have remained employed until the end of the Protection Period
and to have retired on the last day of the Protection Period.

                  (b) Death. If the Executive dies during the Employment Period,
this Agreement shall terminate without further obligation to the Executive or
his estate other than the obligation to pay any compensation or benefits that
have been earned but not paid on the Date of Termination, and any
post-termination, life insurance or death benefits that are provided under the
Company's normal benefit plans and policies; provided that the death benefits
payable to the Employee's beneficiaries or estate shall be at least equal to the
most favorable benefits provided by the Company to the estates and beneficiaries
of peer executives of the Company (taking into account differences in
compensation) under such plans, programs, practices and policies relating to
death benefits, if any, as in effect with respect to other peer executives and
their beneficiaries at any time during the 120-day period immediately preceding
the Change of Control Date.

                  (c) Disability. If the Executive's employment shall be
terminated during the Employment Period by reason of the Executive's Disability,
this Agreement shall terminate without further obligation to the Executive other
than the obligation to pay any compensation or benefits that have been earned
but not paid on the Date of Termination, and any post-termination benefits or
disability benefits that are provided under the Company's normal benefit plans
and policies; provided that the disability benefits payable to the Executive
shall be at least equal to the most favorable of those generally provided by the
Company to disabled executives and/or their families in accordance with such
plans, programs, practices and policies relating to disability, if any, as in
effect generally with respect to other peer executives and their families at any
time during the 120-day period immediately preceding the Change of Control Date.

                  (d) Cause; Other than for Good Reason. If the Executive's
employment shall be terminated for Cause during the Employment Period, or if the
Executive shall resign during the Employment Period other than for Good Reason
this Agreement shall terminate without further obligation to the Executive other
than the obligation to pay any compensation or benefits that have been earned
but not paid on the Date of Termination, and any post-termination benefits that
are provided under the Company's normal benefit plans and policies.

         7. NON-EXCLUSIVITY OF RIGHTS. Nothing in this Agreement shall prevent
or limit the Executive's continuing or future participation in any plan,
program, policy or practice (other than any severance pay plan) provided by the
Company and for which the Executive may qualify, nor, subject to Section 11(f),
shall anything herein limit or otherwise affect such rights as the Executive may
have under any contract or agreement with the Company. Amounts which are vested
benefits or which the Executive is otherwise entitled to receive under any plan,
policy, practice or program of or any contract or agreement with the Company at
or subsequent to the Date of Termination shall be payable in accordance with
such plan, policy, practice or program or contract or agreement except as
explicitly modified by this Agreement.

                                       9
<PAGE>

         8. FULL SETTLEMENT; LEGAL FEES. The Company's obligation to make the
payments provided for in this Agreement and otherwise to perform its obligations
hereunder shall not be affected by any set-off, counterclaim, recoupment,
defense or other claim, right or action which the Company may have against the
Executive or others. In no event shall the Executive be obligated to seek other
employment or take any other action by way of mitigation of the amounts payable
to the Executive under any of the provisions of this Agreement and except as
specifically provided in Section 6(a)(iii), such amounts shall not be reduced
whether or not the Executive obtains other employment. The Company agrees to pay
as incurred, to the full extent permitted by law, all legal fees and expense
which the Executive may reasonably incur as a result of any contest by the
Company, the Executive or others of the validity or enforceability of, or
liability under, any provision of this Agreement or any guarantee of performance
thereof (whether such contest is between the Company and the Executive or
between either of them and any third party, and including as a result of any
contest by the Executive about the amount of any payment pursuant to this
Agreement), plus in each case interest on any delayed payment at the applicable
Federal rate provided for in Section 7872(f) (2) (A) of the Internal Revenue
Code of 1986, as amended (the "Code"); provided, however, that if the contest is
between the Executive and the Company, the Company shall be obligated to pay the
Executive's legal fees and expenses if the Executive prevails to any extent in
such contest.

         9. CONFIDENTIAL INFORMATION. The Executive shall hold in a fiduciary
capacity for the benefit of the Company all secret or confidential information,
knowledge or data relating to the Company, and their respective businesses,
which shall have been obtained by the Executive during the Executive's
employment by the Company and which shall not be or become public knowledge
(other than by acts by the Executive or representatives of the Executive in
violation of this Agreement). After termination of the Executive's employment
with the Company, the Executive shall not, without the prior written consent of
the Company or as may otherwise be required by law or legal process, communicate
or divulge any such information, knowledge or data to anyone other than the
Company and those designated by it. In no event shall an asserted violation of
the provisions of this Section 9 constitute a basis for deferring or withholding
any amounts otherwise payable to the Executive under this Agreement.

         10. SUCCESSORS. (a) This Agreement is personal to the Executive and
without the prior written consent of the Company shall not be assignable by the
Executive otherwise than by will or the laws of descent and distribution. This
Agreement shall inure to the benefit of and be enforceable by the Executive's
legal representatives.

                  (b) This Agreement shall inure to the benefit of and be
binding upon the Company and its successors and assigns.

                  (c) The Company will require any successor (whether direct or
indirect, by purchase, merger, consolidation or otherwise) to all or
substantially all of the business and/or assets of the Company to assume
expressly and agree to perform this Agreement in the same manner and to the same
extent that the Company would be required to perform it if no such succession
had taken place. As used in this

                                       10
<PAGE>

Agreement, "Company" shall mean the Company as hereinbefore defined and any
successor to its business and/or assets as aforesaid which assumes and agrees
to perform this Agreement by operation of law, or otherwise.

         11. MISCELLANEOUS. (a) This Agreement shall be governed by and
construed in accordance with the laws of the State of North Carolina without
reference to principles of conflict of laws. The captions of this Agreement are
not part of the provisions hereof and shall have no force or effect. This
Agreement may not be amended or modified otherwise than by a written agreement
executed by the parties hereto or their respective successors and legal
representatives.

                  (b) All notices and other communications hereunder shall be in
writing and shall be given by hand delivery to the other party or by registered
or certified mail, return receipt requested, postage prepaid, addressed as
follows:

                  If to the Executive:    Kurt P. Rindoks
                                          P.O. Box 1013
                                          Davidson, NC 28036

                  If to the Company:      Kewaunee Scientific Corporation
                                          2700 West Front Street
                                          Statesville, NC 28677
                                          Attention:  Chief Executive Officer

or to such other address as either party shall have furnished to the other in
writing in accordance herewith. Notice and communications shall be effective
when actually received by the addressee.

                  (c) The invalidity or unenforceability of any provision of
this Agreement shall not affect the validity or enforceability of any other
provision of this Agreement.

                  (d) The Company may withhold from any amounts payable under
this Agreement such Federal, state, local or foreign taxes as shall be required
to be withheld pursuant to any applicable law or regulation.

                  (e) The Executive's or the Company's failure to insist upon
strict compliance with any provision hereof or any other provision of this
Agreement or the failure to assert any right the Executive or the Company may
have hereunder, including, without limitation, the right of the Executive to
terminate employment for Good Reason pursuant to Section 5(c) (i)-(v) of this
Agreement, shall not be deemed to be a waiver of such provision or right or any
other provision or right of this Agreement.

                  (f) The Executive and the Company acknowledge that, except as
may otherwise be provided under any other written agreement between the
Executive and the Company, the employment of the Executive by the Company is "at
will" and, prior to the Change of Control Date, the Executive's employment may
be terminated by either the Executive or the Company at any time prior to the
Change of Control Date, in which case the Executive shall have no further rights
under this Agreement. From and after

                                       11
<PAGE>

the Change of Control Date this Agreement shall supersede any other agreement
between the parties with respect to the subject matter hereof.

         IN WITNESS WHEREOF, the Executive has hereunto set the Executive's hand
and, pursuant to the authorization from its Board of Directors, the Company has
caused this Agreement to be executed in its name on its behalf, all as of the
day and year first above written.

                                          /s/ Kurt P. Rindoks
                                          ---------------------------
                                                (Executive)

                                          KEWAUNEE SCIENTIFIC CORPORATION

                                          By:  /s/ Eli Manchester, Jr.
                                             ------------------------
                                          Its: Chairman and CEO
                                             ------------------------

                                       12

<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          APR-30-2000
<PERIOD-START>                             MAY-01-1999
<PERIOD-END>                               JAN-01-2000
<CASH>                                               8
<SECURITIES>                                         0
<RECEIVABLES>                                   14,731
<ALLOWANCES>                                         0
<INVENTORY>                                      3,498
<CURRENT-ASSETS>                                19,781
<PP&E>                                          32,931
<DEPRECIATION>                                  19,632
<TOTAL-ASSETS>                                  35,409
<CURRENT-LIABILITIES>                            8,875
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         6,550
<OTHER-SE>                                      17,653
<TOTAL-LIABILITY-AND-EQUITY>                    35,409
<SALES>                                         56,561
<TOTAL-REVENUES>                                56,561
<CGS>                                           43,408
<TOTAL-COSTS>                                   43,408
<OTHER-EXPENSES>                                 9,522
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 123
<INCOME-PRETAX>                                  3,774
<INCOME-TAX>                                     1,250
<INCOME-CONTINUING>                              2,524
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,524
<EPS-BASIC>                                       1.03
<EPS-DILUTED>                                     1.02


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission